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DNA. Adducts with 2-deoxyguanosine have been characterized for a 
number of aminoimidazoazaarenes. Adducts with DNA have also been 
found in animals after exposure to these compounds. 
In \:iw major metabolic detoxification pathways are ring hydroxylation 
followed by conjugation and conjugation of the exocyclic amino group. 
Estimations of human cancer risk have indicated that ingestion of food 
containing aminoimidazoazaarenes are of importance. 
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SUMMARY 
Several carcinogenic heterocyclic aromatic amines are formed during cooking of meat and 
fish. The important factors for the formation of these compounds are the type of meat 
being cooked, cooking temperature and duration of cooking. Under standard household 
cooking conditions, the aminoimidazoazaarenes (AIAs) which are condensation products of 
amino acids and creatinine, seem to be the most important compounds, due to the amounts 
formed and their possible biological effects. 
The AIAs are genotoxic in a number of test systems such as those using Salmonella 
tyyhimwiw~ and mammalian cells. In rodent feeding studies IQ, 4-MeIQ, 8-MeIQx and 
PhIP were found to be multiple organ carcinogens. 
These procarcinogens require metabolic activation to exert their genotoxic effects. 
Activation has been shomrn to occur via hydroxylation, catalysed by CYPlA enzymes, of 
the exocyclic amino group to the N’-OH derivatives. These derivatives are proximate 
mutagens that to some extent bind covalently to DNA and other macromolecules. Further 
activation of the P-OH group through esterification by e.g. acetyltransferase or 
sulfotransferase results in formation of highly reactive species that form adducts with DNA 
and 2’-deoxyguanosine, but not with 2’-deoxyadenosine, 2’-deoxycytidine or thymidine. 
Adducts from 2’-deoxyguanosine and IQ, 4-MeIQ, 8-MeIQx, 4,8-DiMeIQx and PhIP have 
been characterized. 
In rodents irl vi\*o, major metabolic pathways, that result in detoxification products, are 
hydroxylation of the ring system followed by conjugation with sulphate or glucuronic acid. 
Also, conjugates of the exocyclic amino group with sulphate or glucuronic acid are major 
metabolites. 
3’P-Postlabeling analyses of DNA from rodents given AIA compounds orally as well as 
studies using radiolabelled compounds showed that adducts with 2’-deoxyguanosine are 
also formed ijl 1,iw. Adduct levels seem to increase linearly with dose. 
Risk estimates, based on extrapolations from results of long term animal cancer studies, 
have suggested that ingestion of AIA compound are important in human cancer etiology. 
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PREFACE 
The present study was initiated to provide knowledge about the mechanism of activation 
and DNA binding of the food derived carcinogens PhIP and 4,8-DiMeIQx. PhiP and 4,8- 
DiMeIQx were chosen as representatives of the AIAs that are formed at high and medium 
frying temperatures, respectively. 
Due to the presence of these potentially deleterious compounds in the normal human diet, 
there is a need for developing biomarkers of exposure and effects. Research on the 
mechanism of activation and adduct formation of several AIAs and pyrolysate mutagens 
have been conducted by a number of research groups throughout the world. PhIP, in 
particular, has attracted attention, which has resulted in a strong competitive environment 
but also in the establishment of many collaborative studies. The results presented here form 
part of the contribution to these collaborative international efforts. 
In paper I1 the microsomal metabolism of PhIP and identification of the genotoxic 
metabolite was published. * 
Paper II describes the formation of DNA adducts of PhIP and the structural 
characterization of the adduct. 
In paper III, the microsomal metabolism of 4,8-DiMeIQx and identification of the 
genotoxic metabolites was published. 
Paper IV describes the formation of DNA adducts of 4,8-DiMeIQx and the structural 
characterization of the adduct. 
The studies on PhIP and 4,8-DiMeIQx are planned to continue. The future aims are to 
develop methods for measuring adducts in samples from humans exposed to AIAs by 
ingestion of meat prepared under normal household conditions. The development of such 
biomarkers will be useful in the estimation of individual human cancer risk associated with 
AIA ingestion. 
I wish to thank all of the collaborators for a fruitful corporation. 
From the Institute of Toxicology, Danish National Food Agency: 
Dr. Preben A. Nielsen 
Dr. Eva S. Rasmussen 
Dr. Lars 0. Dragsted 
Dr. John C. Larsen 
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SAMMENDRAG 
Ved stegning af kod og fisk dannes adskillige karcinogene heterocykliske aromatiske 
aminer. De vigtigste faktorer for dannelse af disse stoffer er kod typen, stegetemperaturen 
og varigheden. Ved almindelige stegebetingelser er aminoimidazoazaareneme (AIA), som 
er kondensations produkter af aminosyrer og kreatinin, de vigtigste forbindelser. BBde p8 
grund af mangden de dannes i og den mulige biologiske effekt. 
AIA forbindelseme er genotoksiske i mange test systemer som Salntomlfa typhimurium og 
mammale teller. I langtids studier i gnavere er IQ, 4-MeIQ, 8-MeIQx og PhIP vist at 
medfare kraft i flere organer. 
Disse prokarcinogener krzver metabolisk aktivering for at udvise genotoksisk effekt. 
Aktiveringen er vist at ske ved CYPlA katalyseret hydroxylering af den exocykliske 
aminogruppe til et N’-OH derivat. Disse derivater bindes i nogen grad kovalent til DNA og 
andre makromolekyler. En yderligere aktivering af N’-OH gruppen kan ske ved 
esterifikation katalyseret af acetyltransferase eller sulfotransferase, hvorved der dannes 
meget reaktive derivater, som danner addukter med DNA og 2’-deoxyguanosin, men ikke 
med 2’-deoxyadenosin, 2’-deoxycytidin eller thymidin. Addukter mellem 2’-deoxyguanosin 
og IQ, 4-MeIQ, 8-MeIQx, 4,X-DiMeIQx og PhIP er blevet karakteriseret strukturelt. 
I gnavere iu vi\-o er det vist, at de vigtigste metaboliserings veje son-r fdrer til dannelse af 
detoksifiserings produkter, er hydroxylering af ringsystemet efterfulgt af konjugering med 
sulfat eller glucuronsyre. KOnjugering af den exocykliske amino gruppe n-red sulfat eller 
glucuronsyre er ogsa vigtige metaboliseringsveje. 
+-Postlabeling analyse af DNA fra gnavere, som er doseret oralt med AIA, save1 som 
undersopelser hvor der anvendt radioaktivt mzrkede stoffer har vist at addukter med 2’- 
deoxyguanosin ogsa dannes in \:i\‘o. Addukt niveauet stiger linezrt med dosis storelsen. 
Risiko extrapolering baseret pa langtids studier i dyr indikerer at indtagelse af AIA 
forbindelser er af betydning for udvikling af kraft i mennesker. 
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ABBREVIATIONS 
AaC 
acetyl-CoA 
AIA 
ATP 
CYP 
DiMeIQx or 
4,8-DiMeIQx 
4,7-DiMeIQx 
5,7-DiMeIQx 
5,8-DiMeIQx 
dG 
dG-CS-IQ 
dG-N:-IQ 
dG-C8-MeIQx 
dG-N’-MeIQx 
dG-CS-DiMeIQx 
dG-C8-PhIP 
DNA 
Glu-P- 1 
Glu-P-2 
IQ 
IQx 
MeAaC 
MeIQ or 
4-MeIQ 
5-MeJQ 
4-MeIQx 
7-MeIQx 
MeIQx or 
8-MeIQx 
2-amino-9H-pyrido[2,3-blindole 
acetyl coenzyme A 
aminoimidazoazaarene 
adenosine-5’-triphosphate 
cytochrome P-450 
2-amino-3,4,8-trimethyhmidazo[4,5-fiquinoxaline 
2-amino-3,4,7-trimethylimidazo[4,5-fiquinoxaline 
2-amino-3,5,7-trimethylimidazo[4,5-flquinoxaline 
2-amino-3,5,8-t.rimethylimidazo[4,5-flquinoxaline 
deoxyguanosine 
N2-(deoxyguanosin-8-y&IQ 
5-(deoxyguanosin-N2-yl)-IQ 
ZV’-(deoxyguanosin-8-yl)-8-MeIQx 
5-(deoxyguanosin-N’-yl)-8-MeIQx 
A@-(deoxyguanosin-8-yl)-4,8-DiMeIQx 
N*-(deoxyguanosin-8-yl)-PhIP 
deoxyribonucleic acid 
2-amino-6-methyldipyrido[ 1,2-a:3’.2’-d]imidazole 
2-aminodipyrido[ 1,2-a:3’,2’-d]imidazole 
2-amino-3-methylimidazo[4,5flquinoline 
2-amino-3-methylimidazo[4,5-flquinoxaline 
2-amino-3-methyl-9H-pyrido[2,3-b]indole 
2-amino-3,4-dimethylimidazo[4,5-flquinoline 
2-amino-3,5-dimethylimidazo[4,5-flquinoline 
2-amino-3,4-dimethylimidazo[4,5-flquinoxaline 
2-amino-3,7-dimethylimidazo[4,5-flquinoxaline 
2-amino-3,8-dimethylimidazo[4,5-fiquinoxaline 
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NAT1 
NAT2 
2-nitro-PhIP 
@OH-IQ 
N2-OH-MeIQx 
@-OH-PhIP 
5-OH-IQ 
4’-OH-PhIP 
7-oxo-MeIQx 
PAPS 
PCB 
pdGp-C8-MeIQ 
PhIP 
RNA 
Trp-P- 1 
Trp-P-2 
N-acetyltransferase type 1 
N-acetyltransferase type 2 
1-methyl-2-nitro-6-phenylimidazo[4,5-b]pyridine 
2-hydroxyamino-3-methylimidazo[4,5-flquinoline 
2-hydroxyamino-3,8-dimethylimidazo[4,5-fquinoxaline 
2-hydroxyamino- 1-methyl-6-phenylimidazo[4,5-blpyridine 
2-amino-5-hydroxy-3-methylimidazo[4,5-flquinoline 
2-amino- l-methyl-6-(4-hydroxy-phenyl)imidazo[4,5-~]pyridine 
2-amino-3,6-dihydro-3,8-dimethyl[4,5-flquinoxaline-7-one 
3’-phosphoadenosine-5’-phosphosulphate 
aroclor 1254 
~-(deoxyguanosin-8-y1)4-MeIQ-3’,5’-diphosphate 
2-amino- 1 -methyl-6-phenylimidazo[4,5b]pyridine 
ribonucleic acid 
3-amino- 1,4-dimethyl-5H-pyrido[4,3-blindole 
3-amino- 1-methyl-5H-pyrido[4,3-blindole 
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INTRODUCTION 
Chemical Carcimgenesis 
During the past two centuries it has been recognized that humans occupationally exposed 
to mixtures of chemical compounds, in particular tars from combustion, were at high risk 
of developing cancer. In the beginning of the 20th century the development of cancer in 
experimental animals was reported following repeated application of coal tar onto rabbit 
skin (reviewed by Miller, 1994 and Pitot, 1990). After the introduction of animal models in 
experimental carcinogenesis Kennaway and Heiger in 1930 identified the first pure 
chemicals, dibenz[u&anthracene and dibenz[a,h]anthracene, that could induce cancer 
(Kennaway and Heiger, 1930). 
Since then, several chemicals including polycyclic aromatic hydrocarbons, aromatic 
amines, N-nitroso-compounds, alkylating agents and several naturally occurring compounds 
have been shown to be carcinogens. These different chemical classes of carcinogens do not 
seem to share any structural or chemical similarities. However, in 1961 the Millers 
recognized that a metabolite of N-acetylaminofluorene was a more potent carcinogen than 
the parent compound. This indicated that chemical carcinogens were activated to proximate 
carcinogens by enzymatic processes taking place in the cell (Miller and Miller, 1961). 
Indications that metabolism was involved in the activation of carcinogens was also 
obtained from observations that carcinogens were covalently bound to macromolecules in 
animal tissue. In 1964, Brooks and Lawley discovered, by use of a radioactively labelled 
carcinogen, that DNA was the target molecule for reactive metabolites and they found a 
correlation between carcinogenic potency and DNA binding (Brookes and Lawley, 1964). 
Many of the procarcinogens are lipophilic substances which are subject to modifications by 
phase I and/or phase II enzymes in order to make them more hydrophillic to facilitate 
excretion via urine or faeces. For example, alkyl groups, aromatic rings and amino groups 
may be hydroxylated; nitro groups and azo groups may be reduced; phenolic groups, 
alcohols and amino groups may be conjugated with glucuronic acid, acetate, phosphate or 
sulphate. 
These enzymatic processes usually result in formation of detoxified, water soluble 
metabolites which are readily excreted. However, some of these enzymatic modifications 
may result in metabolites that are more potent carcinogens than the parent compound. 
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Often more than one enzymatic activation reaction is necessary for the formation of 
ultimate carcinogenic metabolites, although, some carcinogens exist in their ultimate form 
(e.g. alkylating reagent) and do not need metabolic activation (Miller and Miller, 1966; 
Dipple, 1988). 
The ultimate carcinogenic metabolites of the various classes of chemical carcinogens have 
one common feature. They are reactive electrophiles, that can react with cellular 
macromolecules. Especially, the reaction of an electrophilic metabolite with nucleophilic 
positions on the DNA bases resulting in the formation of DNA adducts seems to be a 
critical step in the development of cancer. 
It is now realised that the development of cancer is a multistage process where several 
steps are involved. The process has been divided into four stages: initiation, promotion, 
conversion and progression, which each are thought to contain several different events 
(reviewed by Harris. 1991). The first stage, initiation, involves exposure to a carcinogen, 
formation of DNA adducts that result in a mutation leading to an initiated cell. During the 
second stage, promotion, the initiated cell starts to proliferate due to decreased 
responsiveness to regulatory growth factors. In the third stage, conversion, growing 
initiated cells are susceptible to genetic damage by chemical carcinogens resulting in 
conversion to a malignant cell. In the fourth stage, progression. genetic changes in the cells 
result in increased growth rate, the ability to invasive growth and the ability to metastasize. 
Diet and cancer 
Dietary constituents are now considered important factors both in the causation and in the 
prevention of important diseases, including cancer (Willett, 1994, Rogers et al., 1993). The 
diet has been estimated to account for 10% of cancers in some organs and up to 90% of 
cancers in other organs. A mean estimate of 35% has been suggested for the dietary 
importance on the cancer rate in the U.S. population (Doll and Peto, 1981). An association 
between intake of animal fat and cancers in the breast, pancreas and colon has been 
reported. However, in some epidemiological studies colon cancer seems to correlate 
stronger with intake of red meat and with preference for heavily browned meat surface. 
(Giovannucci, 1994: Gerhardson de Verdier. 1991, Willett et al., 1990) 
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Suggested mechanisms for these associations include: (1) Increased tumour incidence due 
to excessive calorie intake. A lower tumour incidence is observed in rodents on a calorie- 
restricted diet compared to controls. (2) Proliferative effects of bile acids on the colonic 
mucosa. (3) Increased iron absorption due to meat ingestion. Iron contributes to the 
production of reactive oxygen species that can damage cellular macromolecules e.g. DNA. 
(4) Formation of carcinogenic chemicals such as N-nitrosamines, heterocyclic aromatic 
amines and polycyclic aromatic hydrocarbons during cooking (reviewed by Ames et al., 
1995). 
The formation of carcinogenic substances in fried meat was for the first time reported in 
1939 by Widmark, who had found that ethanol or petroleum ether extracts of horse meat, 
heat treated at a temperature of 275 “C resulted in the formation of mammary tumours, 
when painted on female mice in the occipital region (Widmark, 1939). In the 1970ies 
Sugimura and coworkers used the newly developed Scrlnzo~ellu mutagenicity assay (Ames 
et al., 1973) to look for mutagenic substances in grilled or broiled fish and meat 
(Sugimura, 1992). This led to the discovery of a series of mutagenic compounds identified 
as heterocyclic aromatic amines. 
Heterocyclic aromatic amines in food. 
Fomatiou aud occwence. 
Since it was first discovered that the charred surface of fish and meat contained mutagenic 
activity corresponding to that of 130-450 pg benzo[a]pyrene/ 100 g of meat (Nagao et al., 
1977), a large number of mutagenic compounds has been isolated from heat processed 
proteins and foods and structurally characterized. The first class of mutagens that was 
structurally characterized was the pyrolysate mutagens which are formed during treatment 
of amino acids or proteins at very high temperatures. Examples of structures of the 
pyrolysate mutagens are shown in Figure 1. Later a second, more abundant class of 
mutagens, the aminoimidazoazaarenes (AIAs), was structurally characterized. The AIAs are 
formed during ordinary cooking conditions and are characterized by one or two 
heterocyclic rings fused to an aminoimidazo ring (Felton, 1986a). Figure 2 shows the 
structures of IQ (Kasia et al., 1980a); 4-MeIQ, (Kasia et al., 198Ob); 8-MeIQx, (Kasia et 
14 
al., 1981): 4,8-DiMeIQx, (Felton et al., 1984) and PhIP (Felton et al., 1986a). The AIAs 
Trp-P- 1 
CHJ 
CH3 
Gh-P- 1 
Trp-P-Z 
~---J?JNH2 
Ghl-P-2 
OZJNH* QJ-J(yH3 
NH N NH2 
AaC MeAaC 
Fig. 1 Structures of selected pgrolysate mutagens 
are found in higher concentrations compared to the pyrolysate mutagens when cooking is 
carried out under normal household conditions. Therefore, the following text will mainly 
concentrate on the AIAs. 
The AIAs that until now have been characterized are subdivided into three structurally 
different groups; the quinolines, the quinoxalines and the pyridines (Figure 2). AIAs have 
been detected in a series of cooked foods including fish, beef, chicken, lamb and pork. The 
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formation of mutagenic substances does not seem to differ between the various sorts of 
meat, but seems to be qualitatively and quantitatively comparable under similar cooking 
conditions. Cooking time and cooking temperature are the most important factors that 
determine the amount of mutagens formed (Skog, 1993). 
QUINOLINES 
,N-b 
IQ 4-MeIQ 
QUINOXALINES 
8-MeIQx 
PYRIDINE 
PllIP 
4,8-DiMeIQx 
Fig. 2 Structures of selected aminomidazoazaarene mutagens. 
During 10 min an almost linear increase was observed in the amount of mutagenicity 
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formed in beef patties fried at 150, 190 and 230 OC, respectively (Knize, 1994). 
Several investigation have shown that the mutagenicity in fried meat increases with 
increasing frying temperature (reviewed by Skog, 1993). For each 50 “C rise in frying 
temperature a doubling of the mutagenic activity has been detected in pork (Nielsen et al., 
1988). Increasing frying temperature also resulted in a different distribution among the 
different AIAs formed. At low frying temperatures, up to 200 “C, mainly the more polar 
AIAs, IQ and MeIQx are formed. At temperatures above 200 “C at shift towards more 
apolar AIAs, especially PhIP takes place (Skog,1995, Felton et al., 1986b). 
Table I. Concentrations of MeIQx, DiMeIQx and PhIP in Ineat samples and pan residues 
calculated as ng/.g cooked product. 
Sample/ 
Cooking 
telnperature 
PC) 
MeIQx 
---____---__ 
[neat residue 
DiMeIQx PhIP 
__-__--_---- -----------_ 
meat residue meat residue 
Pork chop/ 
150 
175 
200 
225 
Bacon/ 
150 
175 
200 
225 
Minute steak/ 
150 
175 
200 
225 
Sirloin steak/ 
150 
175 
200 
225 
Ground beef/ 
150 
175 
200 
225 
ND ND IGD ND ND 0.02 
0.2 0.8 0.04 0.2 0.02 0.8 
0.2 1.9 0.05 0.3 0.02 2.4 
2.6 1.8 1.1 0.5 4.8 3.8 
ND ND 0.2 ND 0.3 0.06 
0.1 ND 0.2 ND 0.2 0.1 
0.7 ND 0.3 ND 0.6 0.8 
23.7 0.9 1.4 ND 4.5 0.3 
ND 0.1 
0.2 1.1 
0.6 2.9 
6.2 23.3 
0.02 0.07 0.02 ND 0.06 0.1 
0.2 0.8 0.2 ND 0.02 0.7 
0.7 3.3 0.3 ND 1.2 6.3 
1.6 2.6 0.6 ND 1.8 5.3 
hD 0.06 ND 0.02 0.01 0.08 
0.2 1.1 0.02 0.2 0.04 0.5 
1.2 5.8 0.4 1.1 0.5 7.2 
2.2 3.3 0.8 0.7 1.1 11.2 
ND 0.1 0.02 0.2 
0.06 ND 0.03 1.0 
0.1 0.4 0.3 0.9 
2.7 4.1 12.7 82.4 
ND. not detected. 
Data frorn Skog et al.. 1995. 
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AIAs are found not only in the surface of the fried meat, often the pan residue contains as 
high or higher levels. Examples of the content of MeIQx, DiMeIQx and PhIP in different 
meat samples and residues fried at different temperatures are shown in Table I. The 
important precursors for the formation of AIAs in foods are creatinine or creatine, amino 
acids and carbohydrate, all compounds that are abundant in meat. Formation of AIAs have 
been modelled by heating mixtures of creatinine and an amino acid or creatinine, an amino 
acid and a carbohydrate; IQ has been formed from creatinine/proline (Yoshida, 1984), 8- 
MeIQx from creatinine/glycine/glucose, (Jagerstadt et al., 1984); 4,8-DiMeIQx from 
creatinine/alanine/fiuctose (Grivas et al., 1985) and PhIP from 
creatinine/phenylalanine/glucose (Taylor et al., 1987). 
Microwave treatment of meat prior to cooking reduced the mutagenicity of cooked meat. 
Microwave treatment for 1 min leaves only 38% of the mutagenicity compared to controls, 
2 min leaves 10% and 3 min leaves 6%. It was suggested that the juice that leaves the 
meat during the microwave treatment contains the precursors for the mutagen formation 
(Felton et al., 1992). 
AIA mutagens and pyrolysate mutagens have also been identified in non meat sources, 
although in lower concentrations. MeIQ has been found in roasted coffee beans; A&, 
MeAcrC, Glu-P-1, Glu-P-2, Trp-P- 1, Trp-P-2 have been found in cigarette smoke 
condensates, airborne particles or diesel exhaust (Kikugawa et al., 1989; Manabe et al., 
1990; Kanai et al., 1990; Manabe et al., 1989; Manabe et al., 1991). PhIP related DNA 
adducts has been detected in urine from smokers of black tobacco. (Peluso et al., 1991). 
PhIP has also been detected in beer and wine (Manabe et al., 1993) 
Mutagenicity and Carcinogenicity 
The AIAs are promutagens and require the presence of a metabolic activation system to 
show mutagenic activity in the Ames Salmor~ella assay. Two strains of Sulmonella have 
usually been used in the detection of mutagenic activity, TA98 and TA1538. Table II lists 
the mutagenic potency of some of the AIAs found in cooked food together with some 
structurally related compounds which have been produced in the search of structural proof 
of the ‘4IAs found in food. It can be seen that some of the AIAs are very potent bacterial 
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mutagens, others are quite weak and that small structural changes have large effects on the 
mutagenic potency (Felton and Knize, 1990). 
Studies on quantitative structure activity relationship has resolved some of the structural 
elements that are of importance for the mutagenic potency. In the IQ and IQx type of 
mutagens higher mutagenic potency as compared to e.g. PhIP is related to the presence of 
Ring 3 with double bonds in conjugation with Ring 2 (Figure 3) and with the number and 
position of nitrogen atoms in Ring 3, e.g. 4-MeIQx is more mutagenic than 4-MeIQ (Hatch 
et al. 1991, Vikse et al., 1993a)(For comparison see Figure 2). 
Table II. Mutagenicity of AIA compounds in Salnmella ty~~hinzwim strain TA98 and 
TA 1538 expressed as revertants/pg. 
Compound TA98 TA1538 
IQ 
4-MeIQ 
5-MeIQ 
4-MeIQx 
7-MeIQx 
8-MeIQx 
4.8-DiMeIQx 
4.7-DiMeIQx 
5.8-DiMeIQx 
S.7-DiMeIQx 
PhIP 
433.000 200.000 
660.000 750.000 
142.000 NT 
NT 875 .OOO 
233.000 528.000 
110.000 93.300 
206.000 320.000 
351.000 38.700 
74 .ooo 3.100 
243 .OOO NT 
2000 NT 
NT. not tested 
Data from: Felton and Knize. 1990 and Felton et al.. 1988. 
Also the presence and position of methyl groups has a strong effect on the mutagenic 
potency. A methyl group in position 4 of IQx results in a higher mutagenic potency than a 
methyl in position 5 and the addition of a methyl group in position 7 of 4-MeIQx results 
in a higher mutagenic potency than addition of a methyl group in position 8 (Vikse et al., 
1993b)(Consult Fig. 2). 
The proposed ultimate mutagenic metabolite of the AIAs is a nitrenium ion generated after 
0-esterification of the proximate mutagenic N’-hydroxylated metabolite (Figure 3). The 
presence of a long conjugated system of double bonds in the AIAs, that is able to 
delocalize the charge on the nitrenium ion will stabilize the ion and increase the 
probability that it will reach DNA before reacting with other cellular nucleophiles (Dipple 
et al., 1968). Recently. molecular orbital calculations on nitrenium ion stabilities of a series 
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of AIAs and pyrolysate mutagens have shown good correlation between mutagenic potency 
and nitrenium ion stability (Ford and Griffin, 1992). 
In the Ames Salnzorzella assay the metabolic activation to the proximate mutagenic 
metabolite takes place outside the bacteria, and it has been proposed that the methyl groups 
in position 3 and 4 will provide a hydrophobic region that facilitates membrane transport. 
Also, methyl groups in certain positions will result in a different metabolic pattern by e.g. 
blocking a detoxification reaction and thereby increasing the mutagenic potency. 
(+) (+) 
Fig. 3 Pattern of resonance delocalization of the positive charge of a 
nitrenium ion of IQ through the x electron system, Hatch et al., 1991. 
The AIAs have been tested for genotoxicity in a large number of mammalian systems both 
irt vitro and in \:ivo with both positive and negative results, possibly as a result of use of 
different protocols, different cell types, different metabolic activation system or none, and 
different doses (reviewed by Munro et a1.,1993). It does, however, seem that the potency 
of the AIAs is reversed as compared to the potency in the Salnzonellu assay, with PhIP 
being more potent in inducing e.g. sister chromatid exchanges than MeIQ and MeIQx 
(Thompson et al., 1987). 
Studies on carcinogenicity after oral treatment have been conducted with IQ, 4-MeIQ, 8- 
MeIQx and PhIP in mice and rats. All were found to be carcinogenic in various organs in 
rodents. A summary of selected oral carcinogenicity studies is shown in Table III. 
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Carcinogenicity studies in monkeys with oral dosing of IQ, MeIQx and PhIP are still 
ongoing. However, already after one-seventh of the expected life span of the monkeys IQ 
which was the first compound tested, turned out to be a liver carcinogen (Adamson et al., 
1994; Table III). 
Table III. Summary of carcinogenicity studies with AIA compounds. 
AIA 
IQ 
Animal Dose 
Species wdkdd 
CDF, M 35.5 
mouse F 31 
Number of animals 
with tumours 
M 27139 
F 27136 
Most sensitive 
tissue 
lung 
liver 
F344 
rat 
M 12 
F 8.6 
M 36140 
F 27140 
Zymbal gland 
zymbal gland 
SD rat F 69.3 14132 mammary gland 
monkey M/F 10 
M/F 20 
1 l/20 
19120 
liver 
liver 
MeIQ CDF, 
mouse 
3s M 12115 
F 16122 
forestomach 
forestomach 
F344 
rat 
M 16 
F 10.9 
M 19120 
F lJJ20 
Zymbal gland 
Zymbal gland 
MeIQx CDF, 
mouse 
M 77 
F 70 
M 15137 
F 32135 
liver 
liver 
F344 
rat 
M 19.4 
F 13.1 
M 20/20 
12/19 
liver 
clitoral pland 
PhIP CDF, 
mouse 
M 86.7 
F 53.3 
M 11/35 
F 26138 
lymphoma 
lymphoma 
F344 
rat 
20 M 16129 
F 14130 
colon 
mammary gland 
Data from Munro et al.. 1993 and Adamson et al., 1994. 
Metabolism 
TJw Qlrinalirles: 2-amino-3-methylimidazo[4.5-flquinoline (IQ) and 2-amino-3,4- 
dimethylimidazo[45flquinoline (MeIQ) 
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In vitro studies have indicated that IQ and MeIQ are activated to mutagenic metabolites by 
microsomes or S9 from various species including mouse, rat, rabbit, monkey and man 
(Yamazoe et al., 1983, Aune et al., 1986, Alldrick et al., 1985, Turesky et al., 1991a, 
Davies et al., 1993). Microsomes from monkeys, however, had a low capacity for 
metabolic activation of IQ. IQ and MeIQ induces unscheduled DNA synthesis in 
hepatocytes from PCB treated rats, and sister chromatid exchanges in V79 cells when co- 
cultured with hepatocytes (Brunborg et al., 1988) The structure of the proximate mutagenic 
metabolite of IQ has been determined as the 2-hydroxyamino derivative, P-OH-IQ 
(Yamazoe et al., 1983). By transfection of cells with murine or human P450 isozymes, it 
has been shown that the activation of IQ and MeIQ to the mutagenic metabolite is 
catalyzed by cytochrome P450 lA2 (CYPlA2). CYPlAl only showed very low capacity to 
activate IQ and MeIQ (Snyderwine and Battula, 1989, McManus et al., 1990). 
Prostaglandin H synthase was also able to activate IQ by oxidation of the exocyclic amino 
group to a nitro group (Morrison et al., 1993, Wild and Degen, 1987). 
CYPlA2 
NHOH 
Fig. 4 Pathways for metabolic activation of IQ. Snyderwine et al., 1992. 
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P-OH-IQ needs further activation by esterification of the hydroxylamino group to exert its 
genotoxic activity. Figure 4. Incubation of N’-OH-IQ with rat hepatic cytosol and 
pentachlorophenol, an inhibitor of both 0-acetyltransferase and sulphotransferase, resulted 
in reduced mutagenicity in Salnzowlla TA98. Incubation with 2,6-dichloro-4-nitrophenol, a 
more specific inhibitor of sulphotransferase, did not result in reduced mutagenicity. This 
indicates that M-OH-IQ is a substrate for rat acetyltransferase but not for sulphotransferase 
(Snyderwine et al., 1988a). Activation of N”-OH-IQ with cytosol from various organs from 
rats and monkeys has shown that there is a large interspecies and interorgan variation in 
the ability to generate DNA binding metabolites by acetyl-CoA, PAPS, L-Proline and 
ATP- dependant activating enzymes (Davis et al., 1993). Studies with human transferases, 
expressed in Saln~o~l~~lla bacteria or by use of human liver cytosol, have shown that p- 
OH-IQ not is a substrate for human sulphotransferase, a poor substrate for acetyltransferase 
isozyme NATl, but is a substrate for human acetyltransferase isozyme NAT2 (Turesky et 
al., 1991a. Chou et al., 1995, Wild et al., 1995). 
Fig. 5 Structures of metabolites of IQ identified in rodents. 
Glut = Glucuronic acid. 
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Ii! \yi\~ studies in rats have shown that IQ and MeIQ are readily absorbed and excreted. 
Within 24 hours after dosing with radiolabelled compounds more than 90% of the 
radioactivity had left the animals, 4565% via the urine and 37-49% via the faeces (Sjodin 
et al., 1984, Inamasu et al., 1989). The major water soluble metabolites of IQ were 
identified as the N2-sulfamate and the 0-sulphate and glucuronide conjugates of a 5- 
hydroxylated metabolite. Minor metabolites were 5-OH-IQ, N2-acetylated IQ, IQ-N- 
glucuronide and demethylated IQ (Inamasu et al., 1989, Luks et al., 1989, St@rmer et al., 
1987, Alexander et al., 1989, Turesky et al., 1986), Figure 5. 
The water soluble metabolites of MeIQ were primarily the 0-sulphate and glucuronide 
conjugates of the 5-hydroxylated metabolite. The N2-sulfamate of MeIQ was much less 
abundant than the N’-sulfamate of IQ. A minor nonpolar metabolite of MeIQ was 
identified as the N’-acetyl derivative (Alexander et al., 1989a). 
The Quilro~~lines: 2-amino-3,8-dimethylimidazo[4,5-flquinoxaline (MeIQx) and 2-amino- 
3,4,8-trimethylimidazo[4,5-flquinoxaline (DiMeIQx). 
III vitro studies have shown that microsomes from rats, humans and monkeys can 
metabolically activate MeIQx to mutagenic metabolites. Microsomes from monkeys 
showed the lowest capacity to activate MeIQx (Davis et al., 1993a). The proximate 
mutagenic metabolite from activation with rat hepatocytes and with human microsomes 
was isolated and identified as the N2-hydroxylated derivative (Turesky et al., 1990, Rich et 
al., 1992, Turesky et al., 1991a). Human CYPlA2 was estimated to account for at least 
66% to more than 90% of the phase I metabolism of MeIQx through hr2-hydroxylation 
(McManus et al., 1990, Rich et al., 1992). Murine CYPlA2 has also been shown to 
activate MeIQx, whereas CYPlAl showed no activity (Snyderwine et al., 1989). 
The phase II activation of p-OH-MeIQx was studied by use of cytosol from various 
organs from rats and monkeys and a large variation was observed in the ability of 
acetyltransferase, sulphotransferase, aminoacyl-tRNA synthetase and phosphatase to 
activate N’-OH-MeIQX, depending on species and organ (Davis et al., 1993b). Studies with 
human transferases expressed in Salmo~wlla or by use of human liver cytosol showed that 
JV2-OH-MeIQx not is a substrate for human sulphotransferase. Human acetyltransferase 
isozyme NAT1 has a low capacity to activate N’-OH-MeIQx, whereas human 
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acetyltransferase isozyme NAT2 has a higher capacity for activation (Turesky et al., 1991a, 
Chou et al., 1995, Wild et al., 1995). 
The metabolism of MeIQx was studied in hepatocytes from rats and ten metabolites were 
characterized. In hepatocytes from uninduced rats N’-sulfamate formation is a major 
metabolic pathway, whereas ringhydroxylation followed by sulphate or glucuronide 
conjugation are major metabolites in rats induced with Aroclor 1254, B-naphtoflavone or 
isosafrole. Formation of the mutagenic N?-hydroxylated metabolite as well as its N- 
glucuronide was also detected. The formation of a 2-nitro derivative is indicated by the 
presence of a conjugate where the 2nd nitrogen atom of MeIQx was displaced by the 
sulphur atom of glutathione (Turesky et al., 1990, Wallin et al., 1989). 
Liver microsomes from PCB induced rats metabolized 4,8-DiMeIQx to two major and 
three minor metabolites. One major and one minor metabolite were identified as the N2- 
hydroxy and the 2-nitro derivatives of DiMeIQx, respectively. Both were mutagenic to 
Salmonella ~phinzwim TA98 without metabolic activation system. The other major and 
two minor metabolites were identified as the 8-hydroxymethyl derivative of DiMeIQx and 
its N’-hydroxy and 2-nitro derivatives. The last two metabolites were mutagenic to 
Sahzonella t;vyhimriunz TA98 without metabolic activation system (III, Frandsen et al., 
1994a), Figure 6. Murine CYPlA2 is the predominant isoform responsible for the 
activation of DiMeIQx to mutagenic species, whereas CYP1 Al shows only little activation 
(Snyderwine et al., 1989). 
NH. ZHOH NO3 
Fig. 6 Structures of metabolites of 4,8-DiMeIQx formed by hepatic 
microsomes from PCB induced rats. III, Frandsen et al., 1994a. 
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III t’h*o studies in rats dosed with “C labelled MeIQx showed that 36-418 of the dose is 
excreted with the urine during the first 24 hours, and l-3% during the next 24 hours 
period. The remaining radioactivity is excreted with the faeces with less than 1% retained 
in the tissues after 72 hours (Sjodin et al., 1989). Several metabolites from urine, bile and 
faeces from rats have been isolated and characterized as: N2-sulphamates of MeIQx, an 8- 
hydroxymethyl derivative together with its N2-sulfamate and 4 (or 5) sulphate conjugate 
(structure uncertain), a N’-glucuronide conjugate, sulphate and glucuronide conjugates of a 
4 (or 5) hydroxylated metabolite, and N2-acetylated and N-demethylated metabolites 
(Sjodin et al., 1989, Turesky et al., 1988, Hayatsu et al., 1987). Both the dose and use of 
enzyme inducers influenced the metabolism of MeIQx, with a higher percentage being ZV’- 
hydroxylated after PCB induction (Turesky et al., 1991b). The metabolic profile in 
monkeys is quite similar to the profile in rats except for the presence of two additional 
metabolites, a N’-glucuronide and 7-oxo-MeIQx. The latter was ascribed as an enteric 
bacterial metabolite of MeIQx (Snyderwine et al., 1995), Figure 7. 
Fig. 7 Structures of MeIQx metabolites characterized in monkeys. 
Glut = Glucuronic acid. Snyderwine et al., 1995. 
An i/r t’i~o study in humans with and without the use of the CYPlA2 inhibitor furafylline 
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showed that CYPlA2, in humans, accounts for 91% of the metabolism of MeIQx, most 
likely via N’-hydroxylation (Boobis et al., 1994). 
An ill \vi\lo study of the metabolism of DiMeIQx in conventional and germ free rats 
indicated that the intestinal flora does not influence metabolism. Major metabolites were 
identified as 8-hydroxymethyl-DiMeIQx and its N2-acetylated derivative (Knize et al., 
1989). 
The Pyleidi~e: 2-amino-1-methyl-6-phenylimidazo[4,5-blpyridine (PhIP). 
Several studies have shown that PhIP is activated to a proximately mutagenic metabolite 
by rat hepatocytes and liver microsomes from rabbit, rat, mouse (Holme et al., 1989, 
McManus et al., 1989. Wallin et al., 1990, I, Frandsen et al., 1991, Buonarati et al., 
1990a). The activated metabolite was identified as the ti-hydroxylated metabolite N2-OH- 
PhIP. The other major microsomal metabolite of PhIP was identified as the 4’- 
hydroxylated product (4’-OH-PhIP), which is a detoxification product with thousand times 
lower mutagenic potency than PhIP (Kurosaka et al., 1992), Figure 8. N’-OH-PhIP has also 
been shown to induce sister chromatid exchanges in CHO cells and DNA strand breaks in 
V79 cells (I, Frandsen et al., 1991, Holme et al.,1989). Rat and mouse CYPlA2 N2- 
hydroxylated PhIP at a high rate compared to other isozymes, and CYPlAl detoxificated 
PhIP at a comparatively high rate (Wallin et al., 1990, McManus et al., 1990, Bounarati et 
al., 1991). Also human liver microsomes have a high capacity for CYPlA2 dependent 
activation of PhIP to hi’-OH-PhiP, however the capacity of human microsomes to detoxify 
PhIP to 4’-OH-PhIP is extremely low compared to rodents. The ratio of N’-hydroxylation 
to 4’-hydroxylation was estimated to 97: 1, 3,3:1, 1,7: 1 in man, rat and mouse respectively 
(Davis et al., 1993a, Zhao et al., 1994, Lin et al., 1995). 
Fig. 8 Structures of microsomal metabolites of PhIP. Wallin et al., 1990. 
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N’-OH-PhIP did not bind covalently to DNA, but addition of rat liver cytosol and PAPS, 
and to a much lesser extent acetyl-CoA, resulted in DNA adduct formation (Bounarati et 
al., 1990b). Human hepatic sulphotransferase activated N2-OH-PhIP to DNA binding 
metabolites by a factor of 3.3 to 12.9 more efficiently than rat liver cytosol (Ozawa et al., 
1994). In one study with Sulmor~ella typhimwium expressing human acetyltransferases it 
was concluded that neither NAT2 nor NAT1 could acetylate r\lz-OH-PhIP to an ultimate 
mutagenic metabolite (Wild et al., 1995). In other studies, however, using human 
microsomes and DNA binding as detection, NAT1 and to a larger extent NAT2 together 
with sulphotransferase and phosphotransferase were found to activate N2-OH-PhIP to a 
DNA binding metabolite (Turesky et al., 1991a, Chou et al., 1995, Lin et al., 1995). 
The metabolism of PhIP ill l’i\~ has been studied in mice, rats and monkeys. Following 
oral administration to mice of “C labelled PhIP, 3 1% of the radioactivity was recovered in 
the urine and 30% in the faeces after 24 hours. HPLC analysis of the urine demonstrated 
the presence of 11 metabolites (Turteltaub et al., 1989). In a study using doses equivalent 
to human dietary intakes, almost 100% of the dose was excreted during 96 hours, 90% in 
urine and 10% in faeces. Only 0.01 - 0.04% of the dose could be detected in the tissues 48 
to 96 after exposure (Turteltaub et al., 1992). In the rat faeces is the major route of 
excretion, accounting for 78% of the dose after 24 hours, 51% was identified as 
unmetabolized PhIP (Watkins et al., 1991a). Several of the urinary and faecal metabolites 
have been isolated and characterized. 4‘-PhIP sulphate and an N-glucuronide of N2-OH- 
PhIP are the major urinary metabolites (Alexander et al., 1889b, Alexander et al., 1991, 
Watkins et al., 1991b, Bounarati et al., 1992), Figure 9. One minor metabolite was 
identified as a conjugate of glutathione, where the sulphur atom of glutathione is attached 
directly to the imidazole ring in position 2. The presence of this conjugate indicates that 
PhIP has been oxidized to 2-nitro-PhIP, as 2-nitro-PhIP has the ability to react with the 
thiol groups of glutathione and rat serum albumin (Alexander et al., 1991, Reistad et al., 
1994). A study in monkeys demonstrated the presence of 4 metabolites in urine, PhIP-4’- 
glucuronide, PhIP-4’-sulphate, 4’-hydroxy-PhIP and an N-glucuronide of N2-OH-PhIP. In 
faeces 4’-hydroxy-PhIP and PhIP were found. PhIP-4’-sulphate was the major urinary 
metabolite accounting for 64-72% of the dose (Snyderwine et al., 1993a). 
An recent ill \:i\*o study in humans with and without the use of the CYPlA2 inhibitor 
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furafylline showed that CYPlA2 accounts for 70% of the metabolism of PhIP in humans, 
most likely via hi’-hydroxylation (Boobis et al., 1994). 
HO 
-0;so GlucO 
Fig. 9 Structures of metabolites of PhIP identified in rat urine. 
Giuc = Glucuronic acid. Kaderlik et al., 1994. 
DNA adduct formation 
Adduct formation of N’-hydroxylated metabolites of AIAs with deoxynucleosides and DNA 
ill \tit~ has been studied for a number of compounds including IQ, MeIQ, MeIQx, 
DiMeIQx and PhIP. 
M-OH-IQ to a small extent binds covalently to calf thymus DNA at neutral pH. By 
reducing pH to 5 a minor increase in binding is observed. Addition of excess acetic 
anhydride to the reaction mixture, resulting in formation of the putative hr’-acetoxy 
derivative of IQ, dramatically increases DNA binding. N”-acetoxy-IQ also reacts with 
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deoxyguanosine forming one major and one minor adduct. No reactions with 
deoxycytidine, deoxyadenosine or thymidine were observed. The major adduct was 
structurally characterized as N”-(deoxyguanosin-8-yl)-IQ (dG-C8-IQ) (Snyderwine et al., 
1988b, Turesky et al., 1992) and the minor adduct as 5-(deoxyguanosin-N?-yl)-IQ (dG-N*- 
IQ) (Turesky et al., 1992). The level of the dG-C8 adduct was approximately 8-10 times 
higher than the level of dG-N’ adduct. HPLC analysis of DNA enzymatically digested after 
reaction with 14C-N2-acetoxy-IQ showed than both adducts had been formed. dG-C8-IQ 
accounted for 70% of bound radioactivity and dG-N*-IQ accounted for 4% of the bound 
radioactivity (Turesky et a1.,1992). ‘H-NMR spectroscopic analysis of the adducts revealed 
that the preferred conformation around the glycosidic bond was the anti form of the dG- 
N*-IQ adduct and the syn form of the dG-C8-IQ adduct. It was suggested that this 
conformational difference may influence the persistence of the two adducts, as the dG-C8- 
IQ adduct is expected to induce greater distortion of the DNA structure than the dG-N”-IQ 
adduct (Turesky et al., 1992), Figure 10. 
Fig. 10 Structures of DNA adducts of IQ. Turesky et al., 1992. 
Adduct formation of 4-MeIQ was studied by use of the 32P-postlabeling assay. N’-OH- 
MeIQ was reacted with the four 2?-deoxynucleoside-3’-monophosphates in the presence of 
acetic anhydride and postlabeling analysis showed that only the guanine nucleotide had 
reacted forming one adduct. The adduct was structurally characterized as N?- 
(deoxyguanosin-8-yl)-MeIQ-3’,5’-diphosphate fpdGp-C8-MeIQ). Postlabeling analysis of 
DNA from livers of mice fed MeIQ, showed a single spot co-eluting with pdG-C8-MeIQ 
demonstrating that MeIQ also binds to C-8 of guanine ill I*~\v (Tada et al., 1994). 
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Like IQ. X-MeIQx produced one major and one minor adduct with deoxyguanosine when 
ti-OH-MeIQx was reacted with deoxynucleosides or DNA in the presence of acetic 
anhydride. The major adduct which was formed in 8-10 times higher amounts than the 
minor was characterized as p-(deoxyguanosin-8-yl)-MeIQx (dG-C8-MeIQx). The minor 
adduct was characterized as 5-(deoxyguanosin-n-yl)-MeIQx (dG-N’-MeIQx). ‘H-NMR 
studies revealed that dG-C8-MeIQx has acquired a syn conformation around the glycosidic 
bond, whereas dG-N’-MeIQx is in the anti conformation (Turesky et al., 1992), Figure 11. 
In a 3’P-postlabeling study dG-C8-MeIQx was also detected as the major adduct formed 
when 3’-deoxyguanosine monophosphate reacted with p-OH-MeIQx in the presence of 
acetic anhydride. In liver DNA from rats given MeIQx intragastrically, dG-C8-MeIQx, was 
also the major adduct formed, together with some minor unidentified adducts (Ochiai et al., 
1993). 
dG-CS-MeIQu 
Fig. 11 Structures of DNA adducts of MeIQx. Turesky et al., 1992. 
Reaction of the putative N’-acetoxy derivative of 4,8-DiMeIQx, formed by acetylation of 
N’-OH-DiMeIQx, with deoxynucleosides resulted in the formation of only one adduct. The 
structure was characterized as N’-(deoxyguanosin-8-yl)-4,8-DiMeIQx (dG-C8-DiMeIQx) 
and NMR studies showed that the adduct has a syn conformation around the glucosidic 
bond, Figure 12. Absence of formation of a minor adduct of 4,8-DiMeIQx, although, 
structurally similar to MeIQx was ascribed to the presence of the 4-methyl group, which 
will sterically hinder attack of C-5 of 4,8-DiMeIQx on guanine-N’ . n;‘-acetoxy-4,8- 
DiMeIQx also formed dG-C8-DiMeIQx as the major adduct with calf thymus DNA, 
together with some minor adducts. The minor adducts had UV spectra similar to dG-C8- 
4,8-DiMeIQx and could be hydrolysed to dG-C8-4,8-DiMeIQx by nuclease Pl, indicating 
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that the minor adducts was incompletely digested oligomers. In W?O, dG-C8-DiMeIQx was 
also the major adduct formed in liver DNA from rats dosed with 4,8-DiMeIQx (IV, 
Frandsen et al., 1994b). 
OH 
dG-C8-DiMeIQx 
Fig. 12 Structure of the DNA adduct of 4,8-DiMeIQx. IV, Frandsen et al., 
1994b. 
N’-OH-PhIP, in contrast to N’-hydroxylated metabolites of other AIA, does not react to any 
extent with DNA or nucleosides. Acetylation with acetic anhydride to form the N*-acetoxy 
derivative increases the reactivity. However, this compound is sufficiently stable to allow 
isolation and characterization (II, Frandsen et al., 1992). N*-acetoxy-PhIP reacts with 
deoxyguanosine and its 3’-phosphate, but not with other deoxynucleosides, forming one 
adduct that has been identified as N’-(deoxyguanosin-8-yl)-PhIP (dG-C8-PhIP) and its 3’- 
phosphate (II, Frandsen et al., 1992, Lin et al., 1992, Nagaoka et al., 1992), Figure 13. 
dG-C&Pi-D 
Fig. 13 Structure of the DNA adduct of PhIP. II, Frandsen et al., 1992. 
N’-acetoxy-PhIP also reacts with DNA forming an adduct that by HPLC following 
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enzymatic hydrolysis was identified as dG-C8-PhIP (II, Frandsen et al., 1992). “P- 
postlabeling analysis of DNA modified ill vitro also showed dG-C8-PhIP as the major 
adduct, together with some minor adducts (Lin et al., 1992). Analysis of DNA from rats 
given PhIP orally revealed the presence of dG-C8-PhIP as the major adduct formed in vivo 
(II, Frandsen et al., 1992, Lin et al., 1992). 
Mechanism of adduct formation 
The electrophilic metabolites of the AIAs generally formed major adducts at the C-8 
position of guanine, only minor adducts of a few of the AIAs are found at the N’ position 
of guanine. The C-8 of guanine is only weekly nucleophilic and other alkylating or 
aralkylating agents tend to react with position N-7, O6 or N’ of guanine. It has been 
suggested that the formation of C-8 adducts of aromatic amines is a rearrangement product 
of an initially formed adduct with the more nucleophilic N-7 position of guanine. Evidence 
for this theory has been obtained by reacting N2-acetoxy-2-aminofluorene with 
deoxyguanosine, methylated in position C-8 to prevent rearrangement. 
I, II 
II, In H2N 
Sugar 
Fig. 14 Sites of substitution of 2’-deoxyguanosine. I: Sites modified by 
aikylating agents. II: Sites modified by arylaminating agents. III: Sites 
modified by aralkylating agents. Dipple, 1995. 
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The adduct obtained from this reaction was shown to have a structure where the N-7 
position of guanine was attached to the exocyclic amino group of 2-aminofluorene 
(Humphreys et al., 1992). The evidence for initial adduct formation at the N-7 position of 
guanine, a common position for reaction with electrophilic alkylating agents, led to an 
attempt to make a general mechanistic explanation of the selectivity of adduct formation 
by alkylating, aralkylating and arylaminating ultimate electrophilic metabolites (Dipple, 
1995). 
Alkylating agents tend to react at the O6 and N-7 positions of guanine, arylaminating agent 
form major adducts at position C-8 of guanine (rearranged from N-7) and minor adducts at 
position N2 and aralkylating agents react almost exclusively at the N’ position of guanine, 
Figure 14. 
The theory is based on model studies of the benzylation of guanosine, and the difference in 
product distribution was ascribed to differences in the reaction character, S,l or SN2, and 
ability of the developing ion to delocalize charge, Figure 15 (Moschel et al., 1979, 
Moschel et al., 1980, Moschel et al., 1986)). The theory suggests that reaction through a 
S,2 mechanism results in formation of a N-7 guanine adduct, reaction through a SNl 
mechanism will result in 0” adduct formation if the charge on the ionized intermediate is 
localized and in N’ adduct formation if the charge is delocalized. 
sN2 Rx+y- - RY+ X- 
sN1 RX- R+ + X- ’ y RY + X- 
Fig. 15. 
However, the evidence for the character of the reactions is limited. The theory has recently 
been questioned as theoretical basis was provided that some of the carbonium ions which 
in the above theory are assumed to react by an S,l mechanism can not possibly do so, 
because they are too unstable to exist (Loechler 1994). 
The selectivity in adduct formation on guanine may instead be hypothesized by use of the 
concept of hard and soft nucleophiles/electrophiles, according to which hard electrophiles 
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tend to react with hard nucleophiles and soft electrophiles tend to react with soft 
nucleophiles (Carey and Sundberg, 1990). Other factors that have to be taken into 
consideration are that the free energy of the products has to be lower than the free energy 
of the reactants and that steric hindrance may prevent formation of certain adducts. 
Using the hard-soft/nucleophile-electrophile concept, alkylating agents of the RCH,X type, 
which are soft electrophiles, will react with soft nucleophiles, O6 and N-7 of guanine. Also, 
nitreniumions derived from arylaminating agents are soft electrophiles and tend to react at 
positions O6 and N-7 of guanine (rearranging to a C-8 adduct). Some arylaminating agents 
also to a lesser extent react with N* of guanine, which is borderline between hardness and 
softness. Reaction at the N’ position affords that the electrophile is able to delocalize 
charge into the aromatic ring system so reaction takes place via a harder carbon 
clectrophile. 
Carbonium ions derived from aralkylating agents are borderline between hard and soft 
electrophiles and will react with N’ of guanine, Figure 14. 
DNA adduct formation in vivo 
Numerous studies have been conducted to study DNA adduct formation of heterocyclic 
aromatic amines iu \*il,o. 
IQ-DNA adducts have been detected by 32P-postlabeling analysis in liver, heart, kidney, 
colon, stomach and bladder in rats after oral administration of IQ (Yamashita et al., 1988, 
Overvik et al., 1991, Snyderwine et al., 1988~). Several adducts were detected in each 
organ, including a dG-C8-IQ adduct. Total adduct levels were highest in liver followed by 
kidney, colon, stomach and bladder (Snyderwine et al., 1988~). Studies using multiple 
dosing (5 or 50 mg/kg/dayj for up to 15 days have shown that accumulation of adducts in 
several organs occurred in a dose and time dependant manner (Schut et al., 1994). Also, 
3’P-postlabeling analysis of liver DNA from monkeys dosed with IQ revealed that dG-C8- 
IQ is the major adduct formed in monkeys (Snyderwine et al., 1993b). 
Several DNA adducts of 4-MeIQ have been detected in the liver of CDF, female mice fed 
0.04% MeIQ in the diet. However, addition of nuclease Pl and phosphodiesterase digestion 
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to the “P-postlabeling procedure reduced the number of adducts to a single spot, identified 
as the dG-C8-MeIQ adduct (Tada et al., 1994). 
DNA-adduct formation was studied in mice given a single oral dose of i4C labelled 8- 
MeIQx. Adduct levels were higher after 6 hours than after 24 hours, with the liver having 
the highest adduct level followed by large intestine, stomach, spleen, small intestine, 
kidney and lung (Alldrick and Lutz, 1989). By use of accelerator mass spectrometry, it was 
shown that the adduct level in mouse liver was linearly related to the dose down to an 
exposure as low as 500 q/kg bw, the lowest dose administered (Turteltaub et al., 1990). 
32P-Postlabeling analysis of DNA from various organs of rats treated with 20 mgikg 
bw/day, 5 days per week for two weeks, showed highest adduct level in the liver followed 
by kidney, heart and colon (Davis et al., 1993a). A study of the dose-response relationship 
in adduct formation in liver DNA of rats receiving 0.04, 0.4, 4, 40 and 400 ppm in the diet 
for one week revealed a linear response in adduct formation. Continued dosing at the 
highest level for 61 weeks resulted in induction of hepatocellular carcinomas (Yamashita et 
al., 1990). The structure of the major adduct formed in the rat in \J~W was identical to the 
major adduct formed ill 1~in.0, dG-C8-MeIQx (Ochiai et al., 1993). Also in monkeys dG- 
C8-MeIQx was the major adduct found in liver DNA following treatment with MeIQx. 
The adduct level, however, was much lower than the adduct level found in rats treated at a 
comparable dose level (Snyderwine et al., 1993b, Davis et al., 1993a). 
Several DNA adducts of 4,8-DiMeIQx were detected by 32P-postlabeling analysis in rat 
liver DNA following oral administration of 4,8-DiMeIQx (Yamashita et al., 1988). By 
comparison with a synthetic standard the major adduct formed irr IJ~VO, accounting for 60- 
70% of the bound carcinogen, was identified as dG-C8-DiMeIQx (IV, Frandsen et al., 
1994b). 
DNA adduct formation of PhIP has been studied in various organs of mice, rats, monkeys 
and humans. 
32P-Postlabeling analysis of DNA from mice given a single oral dose of PhIP at 0, 1, 10, 
and 20 mg/kg bw showed highest adduct level in pancreas followed by thymus, heart and 
liver. The adduct level increased linearly with dose (Turteltaub et al., 1993). Also in rats 
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given a single oral dose of 0, 0.5, 5 and 50 mg&g bw a dose related increase in adduct 
level was observed. The highest adduct levels were found in the large intestine followed by 
white blood cells, stomach, small intestine, kidney, liver and lung (Schut and Herzog, 
1992). Studies in monkeys receiving either a single or multiple oral doses of 20 mgJkg bw 
showed that, upon multiple dosing, DNA adducts tend to accumulate in certain organs. 
Adduct levels in liver, pancreas, kidney, small intestine and colon increased 1.5 to 2.4 fold 
after multiple dosing for 10 days, adduct level in brain increased 5 fold, heart 10 fold and 
aorta 31 fold (Snyder-wine et al., 1994). 
The structure of the major adduct found in rat liver DNA after a single oral dose of PhIP 
was shown by chromatographic comparison to be identical to the adduct formed in vitro, 
dG-C8-PhIP (II, Frandsen et al., 1992, Lin et al., 1992). 
In a pilot study with human DNA samples, using both GC/MS and “P-postlabeling 
analysis, evidence for PhIP-DNA adducts was found in two of six colon samples. PhIP- 
DNA adducts were not detected in samples from pancreas or urinary bladder (Friesen et 
al., 1994). 
-“P-Postlabeling analyses of DNA adducted with AIA compounds have resulted in 
considerable interlaboratory variation, with up to six adduct spots being detected for each 
compound. However, inclusion of nuclease Pl digestion in the postlabeling analysis was 
recently shown to reduce the number of adduct spots to one or two, in accordance with the 
adducts characterized after i/r I-itr-o formation. The additional adduct spots usually detected 
in 32P-postlabeling analysis are suggested to be adducted oligonucleosides that are resistant 
to hydrolysis by micrococcal nuclease or spleen phosphodiesterase (Pfau et al., 1994, 
Fukutome et al., 1994). 
Estimates of human intake and cancer risk 
The concentration of heterocyclic aromatic amines (HAA) in cooked meat and fish is in 
the ppb range and large variations in concentration depending on meat type, frying 
temperature and frying time have been observed. This together with interindividual 
consumption habits will markedly influence the daily exposure of individual humans to 
heterocyclic aromatic amines. 
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An average daily intake has been estimated to 0.4 - 16 ug for the Japanese population 
(Wakabayashi et al., 1992). For the German population the average daily intake was 
estimated to 0.8 - 8.4 pg based on an annual consumption of 56 kg of meat and 5 kg of 
fish (Eisenbrand and Tang, 1993). Based on an annual consumption of 56 kg of meat and 
9 kg of fish the intake was calculated to be 0 - 16.5 pg per day in the Danish population 
(Dragsted, 1994). By combining the concentrations of heterocyclic aromatic amines found 
in foods cooked under normal household conditions with a dietary survey of the U.S. 
population, daily intakes of PhIP, MeIQx, DiMeIQx and IQ have been estimated to 16.64, 
2.61, 0.81 and 0.28 pg respectively (Layton et al., 1995). 
Cancer risks associated with intake of HAAs have been estimated by combining the above 
intake estimates with the TD,, from animal tumour studies, mostly in rats, assuming a 
linear dose-response relationship. The assumption of linear dose-response relationship has 
been supported by linearity in DNA binding over a dose range covering 5 orders of 
magnitude down to a single dose of 500 ng/kg of MeIQx (Felton et al., 1992). The 
published cancer risk estimates associated with HAA ingestion vary from 1 in 1000 (Felton 
et al., 1992) to approximately 1 in 10,000 (Gaylor and Kadlubar, 1991, Layton et al., 
1995). A total lifetime cancer risk interval of 0.2 - 2300 per million individuals has been 
estimated for the danish population (Dragsted, 1994). In a risk assessment covering five 
HAA’s: PhIP, MeIQx, DiMeIQx, IQ and A&, ingestion of PhIP accounted for almost 
50%, of the cancer risk (Layton et al., 1995). 
Conclusion 
Several heterocyclic aromatic amines of the AIA type are formed during cooking of meat 
and are found in amounts ranging from “not detected” to more than 80 @kg. The most 
important factors for the formation of the these compounds, both on the meat surface and 
in the pan residue, are the type of meat being cooked, cooking temperature and duration of 
cooking. 
The most important of the AIA compounds, both due to the amount formed and due to 
possible biological effects, seem to be IQ, 4-MeIQ, 8-MeIQx, 4,8-DiMeIQx and PhIP. 
These AIA compounds are genotoxic in a number of test systems including bacterial and 
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mammalian systems. 
Metabolic activation is required for these compounds to exert their mutagenic effect and 
hydroxylation of the exocyclic amino group has been shown to generate the proximate 
mutagenic metabolite. Further activation by transferases such as acetyltransferase, 
sulphotransferase, phosphotransferase or arninoacyltransferase to generate DNA binding 
metabolites are usually required. 
IQ, MeIQ, MeIQx and PhIP were found to be multiple organ carcinogens in oral feeding 
studies in rodents. Also in monkeys IQ was found to be a liver carcinogen. In most of 
these studies, however, adequate data to provide a dose response relationship were not 
obtained (Munro et al., 1993). Furthermore, many of the experiments were terminated 
before the expected life span of the animals (Gold et al., 1994). Risk extrapolation to low 
dose human exposure, which is a factor of 100,000 less than the doses used in animal 
experiments, therefore is associated with great uncertainty. 
Based on animal carcinogenicity data and estimated exposures the human lifetime cancer 
risk from ingestion of AIA compounds has recently been estimated within the range of 1 - 
38 per 100,000 (Layton et al., 1995). In animals, however, metabolic transformation to 
non-genotoxic metabolites seems to be the major metabolic pathway, whereas in humans 
CYPlA2 mediated transformation to genotoxic metabolites is the major metabolic pathway. 
Assessment of human cancer risk based on animal bioassays may therefore result in an 
underestimation. 
Large interindividual variations are found among humans in the activity of enzymes 
involved in activation and detoxification of chemical carcinogens. This results in 
differences in DNA adduct formation between individuals. Also rates of repair of DNA 
damage caused by chemical carcinogens vary among individuals (Harris, 1989). Large 
interspecies differences in metabolism are found, e.g. the ratio of phase I activation (N’- 
hydroxylation) of PhIP to phase I detoxification (4’-hydroxylation) has been estimated to 
97:l in man, whereas in the rat, which is the species often used in cancer bioassay studies, 
the ratio has been estimated to 3.3:1. Also large interspecies variations in phase II 
activation are observed, the degree of activation depending on the substrate, tissue and 
species (Lin et al., 1995; Davis et al., 1993b). 
Future developments of molecular biomarkers reflecting the exposure or the biological 
response to dietary exposures to AIA compounds, e.g. DNA adducts in urine, may provide 
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the means of identifying the most sensitive individuals. Also information obtained from 
studies on molecular biomarkers in humans and in animals from cancer bioassay studies 
can provide data for more accurate estimations of human cancer risk (Shuker and Farmer, 
1992, Strickland and Groopman, 1995). 
The results from own investigations have elucidated the structures of genotoxic metabolites 
and DNA adducts of PhIP and 4,8-DiMeIQx. These results provide a good basis for future 
development of molecular biomarkers based on measurement of DNA adducts, that can 
improve risk assessment of human exposure to these chemicals. 
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derivative of the food mutagen 2-amino-1-methyl-6-phenylimidazo 
(43-b) pyridine (PhIP) 
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Peter Farmer’, Lars Dragsted and John C.Larsen 
institute d Toxicology. National Food Agency. MsrkIvaj Bygade 19. 
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Car&&on, Surrey. UK 
Hepatic microsomes from rats pretreated with PCB were 
found to metabolize the food mutagen %-amino-l-methyl- 
6-phenylimidazo(4,U)pyridine (PhIP) to two major 
metabolites, one of which was identified as the N-hydroxy 
derivative, 2-hydroxy-amino-1-methyla-phenylimidazo(4,5- 
b)pyridine (N-OH-PhIP). This identification was based on 
mass spectral (MS), UV and HPLC data by comparison with 
N-OH-PhIP prepared by chemical synthesis, as well as the 
specific activity of the compound in the Ames Salmonella test. 
Synthetic N-OH-PhIP was prepared by catalytic reduction 
of the nitro derivative of PhIP, which was synthesized from 
PhIP by diazotization and reaction with sodium nitrite. 
N-OH-PhIP was mutagenic to Salmonella typhimurium TA98 
without metabolic activation and had a specific mutagenic 
activity of 2700 revertants/nmol. N-OH-PhIP thus seems to 
be a proximate mutagenic metabolite of PhIP. Other direct 
acting mutagens were not detected in the microsomal incuba- 
tion mixture after HPLC separation. N-OH-PhtP also induced 
sister chromatid exchange (SCE) in Chinese hamster ovary 
cells (CHO cells) without metabolic activation. The specific 
activity of N-OH-PhIP in this assay was - 3 times higher 
than the activity of PhIP with microsomal activation. 
introduction 
During cooking of meat several hetero-aromatic amine mutagens. 
imidazoazaarenes (AIAs). are formed (Felton et al., 1986a,b; 
Nielsen er al.. 1988). When frying at high temperatures, PhIP 
on a weight basis accounts for - 80% of the mass mutagenic 
material produced and - 207~ of the mutagenic activity as deter- 
mined in the Ames Salmonellaimammalian microsome assay. 
Although the specific activity of PhIP in this assay is less than 
several of the other AIAs. recent studies have shown that PhIP. 
in contrast to the other AIAs is a potent mutageniclastogen in 
mammalian cells inducing SCE and chromosomal aberrations in 
repair deficient CHO cells (Thomson et al., 1987). PhIP was 
also found to be a potent inducer of SCE in V79 cells co-cultured 
with Aroclor-pretreated hepatocytes (Holme et al.. 1989). 
Severai studies on the metabolism of aromatic amines. 
including AIAs, show that these substances can be metabolically 
activated by rnicrosomal oxidation of the exocyclic amino group, 
and that resultant N-hydroxy compounds are direct acting 
mutagens in the Ames Salmonella test (Kadlubar and Beland. 
1985: Yamazoe et al.. 1988; Synderwine et al.. 1987: Holme 
et al.. 1989). 
We have studied the metabolic activation of PhIP in 
microsomes from rats pretreated with polychlorinated biphenyls 
(PCB) and isolated a substance which was identified as 
2-hydroxyamino-l-methyl-6-phenylimidazo(4.5-b)pyridine 
c Oxford University Press 
(N-OH-PhIP). The identification was based on comparison with 
chemically synthesized N-OH-PhIP, including mass spectral 
(MS), UV and HPLC data as well as the specific mutagenic 
activity in the Ames test. Moreover the NMR spectrum of 
synthetic N-OH-PhIP as well as its specific mutagenicity in the 
SCE assay are presented. 
Materials and methods 
Chemicals and apparatus 
PhIP was hndly donated by Drs James Felton and Mark Knize. Lawrence Liver- 
more National Laboratory. USA. The PhlP was judged > 99% pure by HPLC 
(316 nm). 2-Amino-4’-h~droxy-1-merhvl-6-phen~limidazo~4.5-~~pyridine 
(4’.hydroxy-PhIP) was kindly donated bq I% Jan Alexander. National Institute 
of Public Health. Oslo. Norway. lsocitric dehkdrogenase (from porcine heart). 
nicotinamlde-adeninedinucleotide-phosphate. Trisodlum-oL-isocitrate and Tris 
(Trizma Base) were obtained from Sigma. St Louis. MO, USA. PCB (Aroclor 
1254) was obtained from Monsanto Industrial Chemical Co.. St Louis. MO. USA. 
HPLC grade methanol was obtained from Rathbum. Walkerbum. UK. C-18 Sep- 
Pak columns were obtained from Waters, Milford. MA, USA. All other chemicals 
were obtained from Merck. Darmstadt. FRG. and were of analytical purity, except 
palladium on carbon and hydrazine hydrate which were of reagent grade. The 
Salmonella tester strain TA98 uas kindly provided by Professor Bruce N.Ames. 
University of CaIifomia. Berkeley. CA. USA. CHO cells (CHO KI. no. 03403-83) 
were from Flow. Rickmanswonh. UK. UV spectra were recorded on a Shimatzu 
UV-160 double beam spectrophotometer. Mass spectra of the electron impact 
(EI) mode were recorded on a VG 7C-2505 at an electron energy of 70 eV. Positive 
fast atom bombardment (FAB) mass spectra were recorded at 8 kV using xenon 
as neutral beam and glycerol as matrix. HPLC was performed on a Hewlea- 
Packard model 1084 B liquid chromatograph. For analytical puroses a 250 x 
4.6 mm Lichrosorb RP-18. 5 pm column (Merck. Dannstadt. FRG). flow 
I mI!nun was used. For preparative purposes a 300 x 7.6 mm Llchrosorb RP-18. 
5 pm column. flow 2.8 ml’min u% used Solyen&: A. 50 mM ammonium acetate: 
B. methanol. For both analytical and preparative purposes the following solvent 
programme was used: IO% B for 5 min followed by a linear gradient to 60% 
B at 25 min. isocratic from 25 to 35 min and a linear gradient to 100% B at 
40 min. Plasma spray liquid chromatography (LC) MS was performed on a VG 
Trio-3 coupled with a Waters 600 multisolvent delivery system. The solvents 
were 20 mM ammonium acetare and 20 mM ammonium acetate in 90% 
acetonitrile. The same column. flow and solvent programming as in analytical 
HPLC were used. NMR spectra were obramed in the solvents specified with a 
Varian VXR-400 m NMR spectrometer. The oxygen electrode was from pHOX 
Systems Ltd. Ivel Road. Shefford. UK. 
S~nrhesis of 2-nirro-l-merh~l-6-phen~litnida~o(4,5-b~p~ridine (NOz-PhfP) 
PhIP (5.2 mg) was dissolved in a mixture of 0.5 ml phosphoric acid (85%) and 
0.2 ml sulphuric acid. The solution was cooled on ice-water and four 5 pl portions 
of 2 M sodium nitrite uere added during a 2 min period under vigorous stirring. 
The solution was stirred at 0°C for 50 min. The diazotization mixture was added 
dropwise to an ice-water cooled solution of 1.4 g sodium nitrite in 15 ml of water. 
The pH of the reaction mixture was kept at 3.5 by addition of first sulphuric 
acid and then 2 M sodium hydroxide. The mixture was heated to rmrn temperature 
and after stimng for 25 min extracted twice with 25 ml of ethylacetate. The organic 
phase was washed with Nater. dried with magnesium sulphate and evaporated 
to dryness. The oily residue was dissolved in 0.5 ml of methanol and NOI-PhIP 
was obtamed as yellow crystals after addition of 1 ml of water and cooling. Yield 
2.6 mg (44% 1. The NO:-PhIP was Judged > 95% pure by HPLC (254 nm). 
Mass spectrum (EI) m/z 254 (25%). M- and 225 (100%). UV absorption 
maximum in methanol was at 350 nm. The molar extinction coefficient was 
estimated to 11200 M-’ cm-‘. 
A reaction tube containing 3 mg of 10% PdiC was evacuated for 5 min and filled 
uith argon. After addition of 2 ml of methanol the suspension was purged with 
oxygen free argon for 5 min. The suspension was cooled on ice-water and IO ~1 
of hydrazine hydrate (80%) was added under stirring. Stirring was continued for 
30 mm at 0°C before a solution of 2.6 mg of NO,-PhIP in 2 ml of argon-purged 
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methanol was added After IO min \tirrins at O’C. 8 ml of cold. arpon-purered 
methanol was added. dnd &ter crntrifugdtlun the supematant *as isolated and 
evaporated to dTness. The oil\ roldue was dissolved in 0.3 ml of methanol and 
crystals of IV-OH-PhIP were obtamed aftrr addition vf0.7 ml of uater and cooling. 
Yield 1.4 mg (57%). The .V-OH-PhIP was ju:iycd ‘x)“r pure b) HPLC (316 nm). 
The mass spectrum (FAB) contained peaks at 311 (M+H)- and 125. UV 
absorption maximum in methanol \~a> 41 3 IO nm. The molar extmctlon coeffi- 
cient was estimated to 15500 M-’ cm-‘. 
TO a solution of 200 pg ,V-OH-PhIP in 0.5 ml argon-purged dimethylformamide 
was added I mg nitrosobenzene dnd 20 111 acetic acid. .After 18 h at room 
temperature. the solution was evaporated to Jr)ne>s dnd di>>ulved tn 0.5 ml 
acetonitrile and analysed by LC MS. 
Prepararion of microsomes 
Adult male Wistar rats (age 7-8 ueeks. ueight -200 g), dcllvered from 
Mollegard Breeding Center Ltd.. Lille Skensved. Denmark. uere used to prepare 
PCB-induced hepatic microsomes. PCB (Aroclor 1254. 500 mglkg. dissolved 
in corn oil) was injected i.p. 5 da)s before sacrifice and microsomes were prepared 
essentially as described by Lake (1987). The microsomes were stored in liquid 
nitrogen until use. The microsomes were characterized by measuring the concen- 
tration of protein (Sedmark and Grossberg. 1977). of P450 (Lake. 1987): 3. l 
nmol/mg protein and of biphenyl hqdroxqlase activity ~Yamazoe rr ~1.. 198 I): 
2-hydroxy-biphenyl: 3.8 nmole formedimg protein min. 4-hydroxy-biphenyl: 1.5 
nmol fotmed/mg protein min. 
Microsod activation of PhIP 
The incubation mixture consisted of: I mgiml microsomal protein, I unit/ml DL- 
isocitratedehydrogenase, 0.5 mM NADP’ . 10 mM sodium-oL-isocitrate and 
5 tnM magnesium chloride in 50 mM Tris-HCI. 0.15 M KCI pH 7.4. The 
mixture was preincubated for 2 min at 37°C before addition of IO pg PhIP 
(dissolved in 5 ~1 of methanol) per ml incubation mixture. The mixture was 
incubated at 37°C. In order to Investigate the time course of formation of PhIP 
metabolites. aliquots of 0.5 ml were taken at fixed time potnts. After immediate 
addition of 1 ml of cold methanol and <entrifugation. the supematants were 
analysed by HPLC. For the isolation of microsomal metabolites the incubation 
time was 30 t&t, whereafter the incubation mixture was applied on a methanol 
and water washed C-18, SepPak column through a 0.45 pm filter. After washing 
with water the metaboiites were eluted with methanol, evaporated to dryness, 
extracted in a small volume of 50% methanol and separated by preparative HPLC. 
All solvents were purged with argon prior to use. 
Mutation assay 
The mutation assays were carried out by the standard plate incorporation method 
as described by Maron and Ames (1983) with or without S9 mix (I mg 
protein/plate) prepared from Aroclor I 254-induced male Wistar rat liver. In some 
experiments the metabolic activation system was substituted hith 1 mM 
dithiothreitol in order to prevent oxidation of the test substance. To 2 ml of molten 
top agar at 45°C 0.1 ml of S9 mix. 0. I ml of water or 0.1 ml 20 mM dithiothreitol 
was added. After 2 min the test compound. dissolved in 0.1 ml of methanol, 
and 0.1 ml of a 7 h nutrient broth (Ovoid) culture of the test bacteria (1.0 x 
IO9 cellsimi) SalmoneUa gphimurium TA98 were added. After a gentle mixing 
the top agar was poured onto 20 ml minimal glucose plates. The number of His+ 
revertant colonies on each plate was counted after incubation for 18 h at 37°C 
in the dark. The intended dose levels of N-OH-PhIP tested with addition of 
dithiothreitol were 0.02, 0.05. 0.16 and 0.50 nmoliplate. The exact concentra- 
tions were determined by HPLC analysis. Each dose level was tested in duplicates 
and the assays were repeated with new batches of both microsomally formed .V- 
OH-PhIP and 5)nthetic .V-OH-PhIP. The results presented are the mean of these 
two mdeprndent experimenrs. The level of spontaneous revertants ua not increased 
by the addition of dithiothreitol to the assay mixture. 2-Nitrofluorene and 
2-aminoanthracene was used as positive control mutagens and solvent (methanol. 
0. I ml) as negative. 2-Nitrofluorene was tested without S9 mix at a concentra- 
tiun ot’0. I pg plate giving 176 * 76 reiertants/plate and 2-aminoanthracene uas 
tested at a concentration of 0. I pgiplate uith S9 mix giving I II * 32 rever- 
[ants plate. The specitic mutagenic aktivity (revertants’nmol) \\as calculated by 
linear regression analysis. 
SCE ‘ma) 
KI CHO cells (2 x IO’) were seeded in 25 cm’ flasks with IO ml growth 
rnedlum [\lcCu)b utth HEPES buffer tGibco) supplemented \*ith 15s fetal bo\ Ine 
serum (Gibco)]. Penicillin and streptomycin sulphate (Gibco) both at 500 IU!ml 
of medium were used ior all cultures. SCE assays were performed according 
to Dean and Danford ( 1984). Cells were incubated with the test substances for 
7 h ubing 4.5 ml of medium without serum and IO0 ~1 test compound or bolbent 
control (100 pl methanol). N-OH-PhIP was tested with the addition of 0.5 mM 
dithiothreitol to the media. PhIP was tested without the addition of dithiotreitol 
and with 0.5 ml microsome mixture. containing 3 mg!mI of protein. 8 mhl 
MgSO,, 16 mM oL-isccitrate. 0.8 mM NADP’ and 0.4 U/ml isocitrate 
dehydrogenase in 50 mM Tris-HCI, pH 7.6. Separate cultures for analysis of 
mitotic index were hanested by ttypsination after 20 h incubation and stained 
in 37~ Giemsa solution. Mitomycin C (0.1 pgiml medium inducing 4.0 
SCEichromosome) and benzo[a]pyrene (20 rglml medium inducing 1.54 
SCEichromosome) were used as positive controls. 
The oxygen concentrations in control incubation mixtures with or without 
microsomal activation system or with addition of 0.5 mM dithiothreitol was 
measured with an oxygen electrode. For SCE 2 x 25 metaphases were evaluated 
per concentration of PhIP and ,V-OH-PhIP. For mitotic index 2 x loo0 cells 
were evaluated per concentration. Two separate experiments were performed on 
each compound. For statistical evaluation the SCE values were transformed to 
loglll f r+ 1) and hubjected to one-way analysis of variance I.Ag0V.A) to compare 
each treatment group to solbent control. Randomized complete block design 
.ANOVA analysis was used to evaluate differences between replica cultures and 
between cxpenments. Regression analysis were used to test dose-response cumes 
for linearity. 
Results 
Nitro- and hydroxyamino derivatives of PhIP were synthesized 
from PhIP (Figure 1) by modifications of the procedures used 
by Yamazoe et al. (1988) for the synthesis of the corresponding 
derivatives of 2-amino-3.8-dimethylimidazo~4.5-~quinoxaline 
(MeIQ,). Based on HPLC areas at 254 nm the nitro-derivative 
(NO,-PhIP) was obtained in -80% yield. The structure of 
NO,-PhIP was verified by MS (Figure 2) and NMR (Figure 3). 
The EI mass spectrum showed the expected molecular ion at ml: 
254 and ions at 225. M’-NCH3 and 209, M’-0-NCH3. The 
‘H-NMR spectrum of NOl-PhIP in d6-dimethylsulfoxide 
(DMSO) showed a singlet at 6 4.2 (N-CH3). a triplet at 6 7.5 
(H-4’). a triplet at 6 7.6 (H-3’ and H-5’), a doublet at 6 7.9 (H-2’ 
and H-6’), a singlet at 6 8.7 (H-7) and a singlet at 6 9.0 (H-5). 
In the crude reaction mixture a by-product was detected in 20% 
Fig. 1. The two-step synthesis of N-OH-PhIP (I) from PhIP (1). show,mg the intermediate NO,-PhIP (2) and the main side reaction product with an 
molecular ion at ml: = 225 putative11 idsntltied ?-OH-PhIP (3). 
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yield on HPLC. The by-product was purified by preparative 
HPLC and assumed to be 2-hydroxy- 1 -methyl-6-phenylimidazo 
(4.56) pyridine (OH-PNP) (MS. EI /n/:=225. M’. not shown) 
formed by attack on water on the intermediate diazoniumion 
or/and by hydrolysis of NO,-PhIP. No,-PhIP was unstable and 
was, especially in slightly acidic solution. converted to OH-PhIP 
(Figure 1). 
The NO?-PhIP was reduced to N-OH-PhIP (Figure 1) as 
described in Materials and methods. This compound was very 
sensitive to oxygen especially when dissolved in organic solvents. 
A methanolic solution slowly turned red. possibly due to forma- 
tion of the azoxy-derivative of PhIP. 
The positive FAB mass spectrum of IV-OH-PhIP showed the 
expected molecular ion at 241, (M +H)I and an ion at 225 (not 
Fig. 2. EI mass spectrum of NOI-PhIP. 70 eV ionization. solid probe 
inlet mode. shwing the molecular ion at UI’: = 2.54 and daughter ion5 at 
no/; = 225. M--NCH, and at W; = 209. Me-O-NCH:. 
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shown). The ‘H-NMR spectrum (Figure 4) showed a singlet at 
d 3.7 (N-CH3). a doublet 6 7.5 (H-4’). a triplet at 6 7.6 (H-3’ 
and H-5’). a doublet at 6 7.7 (H-2’ and H-6’), and two doublets 
at 6 8.3 and 8.4 (H-7 and H-5). NH and OH protons are not 
seen due to exchange with deuterium. 
Further confirmation that the A;-OH-PhIP had been correctly 
synthesized was achieved through the synthesis of the 
phenylazoxy derivative (Hashimoto er al., 1982). N-OH-PhIP 
reacted slowly with nitrosobenzene in acetic DMF. The reac- 
tion was followed on HPLC and as the N-OH-PhIP peak 
diminished a new peak arose. This product was purified by HPLC 
but a mass spectrum containing the molecular ion could not be 
obtained neither by EI nor FAB MS. However analysis of the 
crude reaction mixture by plasma spray LC MS showed the 
expected molecular ion at 330, (M + H) i for the phenylazoxy 
derivative and an ion at 314, (M+H)‘-0 (Figure 5). 
Two major metabolites were observed when PhIP was 
incubated with hepatic microsomes from rats pretreated with 
PCB. see Figure 6. As seen from Figure 7, the time course of 
the formation of the two metabolites was almost linear for 30 min 
when - 80% of the added PhIP had been consumed. The two 
metabolites were purified by preparative HPLC. One of the 
metabolites (peak b) was identified as N-OH-PhIP, as it gave the 
same mass and UV spectra as synthetic N-OH-PhIP and coeluted 
with this in HPLC. The fraction containing the N-OH-PhIP peak 
was the only fraction showing reactivity in the assay for 
iV-hydroxylated amines by Belanger et al. (1981) and it was 
mutagenic in the Ames tester strain TA98 without metabolic 
activation system. Mutagenic activity without metabolic activa- 
tion system was not detected when the remainder HPLC frac- 
tions were pooled and subjected to analysis. The other metabolite 
(peak a) was characterised by its MS spectrum showing 241, 
(M+H)-. but no 225 peak as N-OH-PhIP. On HPLC it co- 
eluted with a reference sample of 4’-hydroxy-PhIP kindly donated 
Fig. 3. The 100 \fHz ‘H-STIR ,pe<irurn of SO?-PhlP. disol\ed in d,-DXISO. Signal> 31 6 1.2. I .Y. 2.5 and i ? wigmarc from rhe salient. Proton 
aAgnment: smglct at 6 1.2 IS-CH,r. triplet at b 7.5 (H-4’). triplet at b 7.6 tH-3’ and H-5’,. doubler at d 7.9 (H-2’ and H-6’). sinslet at 6 8.7 (H-7) and 
hinplrr dt ii 9.0 (H-5). 
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Fig. 4. 100 MHz ‘H-NMR qxcrrum of .V-OH-PhIP. dkolved m D1O made xidic to pH 1 \\Ith DCI. Signals at 6 1. I. 1.8 and 8.2 originate from the 
solvent. Inset: the aromatic region enlarged. Proton aAynment: singlet at 6 3.7 (N-CH,). doublet 6 7.5 (H-4’). trIplet at 6 7.6 (H-3’ and H-5’). doublet 
at 6 7.7 (H-2’ and H-6’). and two doublets at d 8.3 at1d 8.4 (H-7 and H-5). NH and OH protons are not seen due to evchanpe with deurerlum. 
by Alexander et al. (1989). indicating the identity of this 
compound. 
N-OH-PhIP purified from either microsomal incubations or 
prepared by chemical synthesis was tested separately for 
mutagenic activity in the Ames tester strain TA98 without 
metabolic activation. and almost linear increases in the foFma- 
tion of mutant colonies with dose were observed. Two different 
preparations of synthesized and metabolically formed ,V-OH-PhIP 
were tested in duplicates and the specific mutagenic activities were 
calculated by linear regression analysis and found to be 2796 & 
237 (mean & SD, r = 0.96) revertants induced per nanomol 
of the metabolically formed IV-OH-PhIP and 2638 f 158 (mean 
f SD, r = 0.98) revertants induced per nanomole of synthetic 
N-OH-PhIP. 
These results were obtained with the addition of 1 mM 
dithiothreitol prior to the addition of the test compound. If 
dithiothreitol was omitted from the incubation mixture N-OH- 
PhIP induced only 180 f 52 (mean f SD) revertants/nmol. 
If dithiothreitol was substituted with a metabolic activation system 
the specific mutagenic activity was 1970 f 100 (mean f SD) 
revertants/nmol. 
The results of the SCE assays are presented in Figure 8. No 
significant differences between replica cultures and between 
experiments were found for PhIP with metabolic activation. The 
same apply to N-OH-PhIP without activation. For both substances 
the lowest concentration tested caused a significant increase in 
SCE (N-OH-PhIP: 0.51 nmoliml, P < 0.01; PhIP: 2.67 
nmol/rnl, P < 0.01). Significant dose dependent increases in 
SCE (linear trend, P < 0.01) were found in all experiments. 
N-OH-PhIP and PhIP induced 0.062 and 0.022 
SCElchromosomeinmol added to the media respectively. At the 
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Fig. 5. Plasma spray LC MS spectrum of 
~-iphen~lazo~cl,~-l-meth~I-6-phen~limiaro~l.5-h~p~ridinr. \ho\r Ing the 
molecular ton at VI/: = 330 (?+I +H)- and a daughter wn at w; = 3 11 
tM+H)‘-0. 
highest doses tested N-OH-PhIP and PhIP induced 13 and 19% 
mitotic inhibition, respectively. The positive controls 
benzo[a]pyrene with metabolic activation and Mitomycin C 
without also significantly increasing the number of SCE. 
The oxygen concentrations in the SCE assay incubations 
mixtures was measured to 8.3 mg/ml without metabolic activa- 
tion system, to 6.1 mg/ml with metabolic activation system and 
to 3.3 mgiml with the addition of 0.5 mM dithiothreitol. 
Discussion 
Several of the heteroaromatic amines formed during frying of 
meat have been shown to be biotransformed into direct acting 
bacterial mutagens by hydroxylation of the exocyclic aminogroup 
(Kadlubar and Beland, 1985; Snyderwine er al., 1987; Yamazoe 
Formation, synthesis and genotoxicity of N-OH-PhIP 
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Fig. 6. HPLC analysis of microsomal PhIP metabolites after 30 min 
incubation. Peak a is identified as 4’-hydroxy-PhIP. Peak b is N-OH-PhIP. 
Peak c ts PhlP. Peak d was also present in a control incubation not 
containing PhIP. 
INCUBAllON l-ME 
Fig. 7. Time course of formation of the tv.o major microsomal PhlP 
metabolites. Each pomt represents the peak area. to the various incubations 
times (minutes). measured at 25-t nm in HPLC analysis. 1 : N-OH-PhIP: *: 
4’-hydroxy-PhIP. 
er al.. 1988: Holme er al.. 1989; Wallin et al.. 1990). Holme 
er al. (1989) and Turteltaub et al.. (1990) have recently reported 
that PhIP is transformed by hepatocytes from PCB-treated rats 
or by microsomes from 3-methylcholanthrene treated mice to the 
directly mutagenic N-hydroxy derivative. Furthermore PhIP 
induced SCE in V79 cells when co-cultured with hepatocytes 
from PCB treated rats. The N-hydroxy derivative was tenta- 
tively identified by its reactivity in a calorimetric assay for 
N-hydroxylated amines and by co-elution in HPLC and identity 
of UV spectra with N-OH-PhIP obtained by enzymatic reduction 
of NO:-PhIP (Holme et al., 1989) or by co-elution in HPLC 
with synthetic N-OH-PhIP (Turteltaub et al., 1990). 
The present study describes a detailed method for synthesis 
of the nitro and N-hydroxy derivatives of PhIP and provides final 
evidence that PhIP, in accordance with the previously published 
results by Wallin et al. (1990) and Turteltaub et al. (1990). is 
metabolized by PCB-induced hepatic microsomes to N-OH-PhIP. 
and that this compound is mutagenic in S.~phirnuriurn TA98 
vvithout metabolic activation. The structure is confirmed by 
comparing MS. UV and HPLC data on the N-OH-PhIP purified 
from microsomal incubations with data on the synthetic N-OH- 
PhIP. Furthermore we have characterized the synthetic N-OH- 
0 1 
0 1 2 3 4 5 6 7 8 9 10 11 12 
nmol compound/ml 
= N-Oti-PhlP * PhlP 
Fig. 8. SCE induced in CHO cells by N-OH-PhIP without metabolic 
activation and induced by PhIP with microsomal activation system. Values 
presented are means + SD of duplicates of two separate experiments. 
PhIP by NMR spectroscopy and by synthesis of the phenylazoxy 
derivative. The HPLC fraction containing the microsomally 
formed N-OH-PhIP shows, as the only fraction, reactivity in the 
assay for N-hydroxylated amines. in analogy with the results 
obtained with synthetic N-OH-PhIP. This further confirms the 
structure and we are also able to show that the specific mutagenic 
activities in S. qdzimuriurn of microsomally formed and synthetic 
N-OH-PhIP are identical. The synthetic N-OH-PhIP was found 
to be directly genotoxic to CHO cells. In this assay N-OH-PhIP 
induced SCE with a specific activity three times higher than PhIP, 
the latter with metabolic activation. This result clearly indicates 
that N-OH-PhIP is a proximate mutagenic metabolite in 
eukaryotic cells as well as in bacteria. 
As N-OH-PhIP is readily oxidized, we found it necessary to 
add an antioxidant to the test mixtures for genotoxic activity, in 
order to obtain reproducible results, If the antioxidant was omitted 
from the incubation mixture, large variations were observed in 
the specific mutagenicigenotoxic activities obtained from different 
experiments. N-OH-PhIP has a four times higher specific 
mutagenic activity in the Ames Salmonella assay than PhIP, after 
addition of a metabolic activation system. This is in agreement 
with that PhIP is only partially metabolized to N-OH-PhIP. When 
the metabolic activation system is substituted with 1 mM 
dithiothreitol the specific mutagenic activity of N-OH-PhIP is six 
times higher than the specific mutagenic activity of PhIP after 
metabolic activation. The lower oxygen content in assay mixtures 
containing dithiothreitol than in assay mixtures containing a 
microsomal activation system can. by improving the stability of 
N-OH-PhIP, account for this higher mutagenic activity of N-OH- 
PhIP. Addition of antioxidants has previously been shown to be 
beneficial in the testing of readily oxidized compounds (Yamazoe 
er al., 1983). Addition of dithiothreitol to a solution of N-OH- 
PhIP did not change the HPLC retention time of N-OH-PhIP and 
dithiothreitol did not induce SCE in CHO cells or His+ rever- 
tants in the Ames test. Thus dithiothreitol does not seem to react 
with N-OH-PhIP but only to exert a protective action toward 
oxidation. 
Mutagens/carcinogens exert their action through reactions with 
DNA. In a preliminary experiment, we were not able to detect 
any reaction between DNA and N-OH-PhIP, when incubated for 
several days at room temperature under oxygen free conditions. 
Although N-hydroxylation seems to be a necessary metabolic step 
in the mutagenicity of PhIP. further activation is apparently 
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needed for reaction with DNA. Studies have shown that aryl 
hydroxylamines are v’ery weak mutagens in an acetyl-CoA- 
dependent 0-acetyltransferase deficient strain of S. nplri~~ri~r~ 
(TA98 1,8-DNP,) (Saito et nl.. 1983). Other studies indicate 
that sulphonylation or acylation of 2-hydroxyamino-3- 
methylimidazo(4.5-Jrquinoline (.V-hydrosy-IQ) by bacterial 
0-acyltransferase or sulfotransferase enhance the reactivity of 
N-hydroxy-IQ towards DNA 5- to 30-fold (Snyderwine et al.. 
1988). Therefore, N-OH-PhIP may need further activation by 
acetylation or sulfonylation of the N-hydroxy group, improving 
the leaving group capability of the hydroxy group and facilitating 
the formation of a reactive nitrene or nitrenium ion. Such reac- 
tive intermediates have been generated by photolysis of the 
arylazide of 2-amino-3-methylimidazo(4.5Jquinoline (IQ) and 
was shown to react with DNA (Wild et nl., 1989). 
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Reaction of the i%acetoxy derivative of 
2-amino-1-methyl-6-phenylimidazo[4,5b]pyridine (PhIP) with 
2’-deoxyguanosine and DNA. Synthesis and identification of 
I%(2’-deoxyguanosin-8-yl) - PhIP 
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institute of Toxicology. National Food Agency. Merkhoj Bygade 19. 
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Sweden 
The direct acting mutagenic Nz-hydroxylated metabolite of 
the food mutagen 2-amino-1-methyl-6-phenylimidazo- 
[4,5b]pyridine (PhIP) does not react with DNA. Upon 
acetylation of the N*-hydroxy-PhIP with acetic anhydride 
two products could be detected. Mass spectrometric analysis 
showed that both products were monoacetyl derivatives of 
#-hydroxy-PhIP. One of the products did not show any 
reactivity towards DNA and is probably the N-acetvl 
derivative of p-hydroxy-PhIP. The other product which is 
most likely to be N*-acetoxy-PhIP reacted with DNA and 
2’-deoxyguanosine but not with 2’-deoxycytidine, 2’-deoxy- 
adenosine or 2’deoxythymidine. The PhIP-2’deoxyguanosine 
adduct was purified and characterized by mass spectral, ‘H 
and [13C]NMR analysis, showing that PhIP like the other 
cooked food mutagen 2-amin&methylimidazo[4,5-pquinoline, 
had reacted with C-8 of guanine forming N -(2’deoxy- 
guanosin-8-yl) - PhIP. HPLC analysis of enzymatically 
hydrolyzed calf thymus DNA which had been reacted with 
N*-acetoxy-PhIP showed one adduct which was chromato- 
graphically and spectroscopically identical to N*-(2’deoxv- 
guanosin-&-yl)-PhIP. HPLC separation followed by liquid 
scintillation counting of hydrolyzed liver DNA from a rat dosed 
with [3H]PhIP showed that radioactivity coeluted with the 
hydrolysis product of the synthetic PhIP- 2deoxyguanosine 
adduct, indicating that PhIP in viva also forms an 
N*-(2’-deoxyguanosin-8-yl) - PhIP adduct. 
Introduction 
The heterocyclic aromatic amine 2-amino- 1 -methyl-6-phenyl- 
imidazo[4,5-blpyridine (PhIP*) is an indirect mutagenic compound 
formed during frying of meat (l-3). PhIP, which constitutes 
- 80% of the mass of mutagenic material in beef fried at high 
temperatures, has been shown to induce sister chromatid exchanges 
(SCEs) in mammalian cells (4-6). PhIP has also been shown to 
induce lymphomas in mice (7). to induce intestinal adenocar- 
cinemas in rats (8). to produce DNA adducts in various organs 
in rats (9) and has recently been found to induce aberrant crypt 
foci in the large intestine of rats (10). 
*Abbreviations: PhIP. 2-amino-I-methyl-6-phenyhmidazo[3..5-blpyridine: SCEs. 
sister chromaud exchanges: $-OH- PhIP . 2-hqdroxyamino- I -methvl-6-ohem I- 
imidazo[45h]pyridine: -&OAc-PhIP. 2-acetoxiarmno-PhIP: Nz-(2’dG:8-vl;- 
PhIP. i~‘-f2’deu~~~anosin-8-~I)-PhLP: PCB. whchlonnated bioheml: FAB: fa\t 
. _  1  ..~--~-- 
atom bombardment: BES. ~\~‘..~-bis(2-hydroxyethyI)-2-aminoethane sulfonic acid, 
DMF. dimethqlformanide: DMSO. dimethylsulfoxide: ,VV’-Ac-*V’-OH-PhIP. 
hi.N-acetylhydroxyamin*PhIP: 2-OH-PhIP. 2-hydroxy-l-methy&phenylimidaze 
[4.5-blpyridine: DEPT. distonionless enhancement b> polarization nansfer: ,@-OH- 
IQ. 2-hydroxyamin+3-methylim&zo[4.5-~quinoline: Glu-P-l. 2-amino-&methyl- 
dip!rido[ l.2-n:3’.2’-dlimidazole. Trp-P-2. 3-amino-I-methyl-SH-pyrido- 
t-l.?-hlindole. 
c Oxford University Press 
PhIP is metabolically activated by hepatocytes or hepatic 
microsomes, from rat, mouse and rabbit, to the proximate 
mutagenic N2-hydroxy derivative (5,6,11- 13), but further 
activation is apparently needed for the formation of an ultimate 
mutagenic metabolite, which is reactive towards DNA (6,12). 
Previous studies have shown that 2-hydroxyamino-l-methyl- 
6-phenylimidazo[4,5-blpyridine (N’-OH-PhlP) can bid covalent- 
ly to DNA after further activation with cytosolic O- 
acetyltransferase or 0-sulfotransferase or acetic anhydride (14,15). 
While PhIP, by [32P]postlabeling, has been shown to form ad- 
ducts with DNA in vivo and in vitro, the DNA adducts have not 
previously been characterized. In this study N2-(2’deoxy- 
guanosin-8-yl) -PhIP [N2-(2’dG-8-yl) -PhIP] was synthesized 
and was shown by HPLC, combined with diode array detection 
or liquid scintillation counting, to be the major adduct formed, 
in vitro upon reaction between DNA in 2-acetyoxyamino-PhIP 
(@-OAc-PhIP) and in tivo in the rat after dosing with [3H]PhIP. 
Materials and methods 
Chemicals and instnmenration 
PhIP was kindly donated by Dr Errol Zieger, Cellular and Genetic Toxicology 
Branch. NIEHS. North Carolina. Non-specifically labeled [‘HIPhIP was made 
from Ph.IP by Amersham. UK. The exact position of tritium in the [3H]PhIP is 
not known. The [3H]PhIP was adsorbed on a SEP-PAK and washed with 0.1 M 
HCI. to remove exchangeable tritium, and eluted with acetonitrile followed by 
purification on HPLC. The sp. act. was 21.1 Ciimol and the radiochemical purity 
was > 95 % M-OH-PhIP was synthesized as previously described (6). Calf thymus 
DNA. Z’deoxyadenosine. Z’dexoycytidine. 2’deoxyguanosine, Z’deoxythymidine 
and nuclease Pl (EC3.1.30.2) from Pencillium cirrim were obtained from Sigma. 
St Louis. MO. Alkaline phosphatase (Escherichia coli C75) was obtained from 
Amersham. UK. Polychlorinated biphenyl (PCB) (Aroclor 1254) was obtained from 
Monsanto Industrial Chemical Co.. St Louis. MO. C,s SEP-PAK columns were 
obtained from Waters. Milford. MA. HPLC grade acetonitrile was obtained from 
Rathbum. Walkerburn. UK. Silica gel 60 (70-230 mesh), silica TLC plates and 
all other chemicals were obtained from Merck. Darmstadt, Germany. 
Evaporations of solvents under reduced pressure were accomplished with a Biichi 
rotary evaporator. HPLC analyses were performed with either a Hewlett Packard 
model 1084 B liquid chromatograph or a Hewlett Packard 1090 M liquid 
chromatograph equipped with a photcdicde array detector. Nucleosil HPLC columns 
were obtained from HPLC technology. Macclestield Cheshire, UK. Spherisorb 
HPLC columns were obtained from Phase Separation, Deeside Ind. Est., 
Queensferry. Cluyd. UK. Positive fast atom bombardment (FAB) mass spectra 
were recorded at 8 kV using Xenon as neutral beam and glycerol or glycerol/ 
4-toluenesulfonic acid as matrix. Positive ion thermospray LC-MS was performed 
on a Kratos Profile mass spectrometer equipped with a thermosptay interphase. 
The solvent was 50% 0.1 M ammonium acetate pH 4.5 in acetonitrile, flow 
1 mI/min. source temperature 73°C. NMR spectra were recorded with a Varian 
VXRloo FT spectrometer with DMSO-d, as solvent. Radioactivity was measured 
with a Packard Tri-Carb 460 CD liquid scintillation cwnter with external 
standardization. 
Acetydziott of hF-OH-PhlP 
660 pg of I%“-OH-PhIP (2.75 pmol) was dissolved in 0.5 ml argon purged 50% 
dimethylformamide in water and cooled to 0°C. Three times 3 ~1 of acetic anhydride 
Has added during 10 min uith stirring. After a further 10 min stirring at 0°C. 
HPLC analysis of the reaction mixture showed that two major products had been 
formed (Figure I ). Both products were purified by HPLC on a Nucleosil C,,. 
5 pm semi-preparative column (250 X IO mm) at room temperature with a flow 
rate of 2.0 mlimin. The eluents were 20 mM triethylamineMCl pH 4.5 in I: water 
and II: ethanol. Elution programming: 20% II by-3 min. lit& gradient to 50% 
II by 8 min. isocratic 50% II from 8 to 13 min and a linear gradient to lOOF 
U by 20 min. The fractions containing the two products were co&ted under argon 
629 
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and evaporated to dryness without heating on a rotary evaporator and analyzed 
by positive FAB mass spectrometty. One major acetylation product. peak B. ten- 
tatively identified as N’-OAc-PhIP. (Figure 1) was obtained when 5 gl acetic acid 
was added prior to the addition of acetic anhydride. This methodology was used 
in the rest of this work. 
Reaction of N2-OAc-PhlP with 2’-deoxynucleosides and purificarion of 
ti-Q’dG+&-PhlP 
2’-DeoxytlucleQsidcs: 2’deoxyadenosine, 2’-deoxycytidine, 2’-deoxyguano5itK and 
2’deoxythymidine were dissolved at a concentration of 1 mg/mi in 0.1 M N-N- 
bis(2-hydroxyethyl)-2-aminoethane sulfonic acid (BES)INaOH pH 7.4. Two ml of 
each solution and a control not containing 2’deoxynucleoside were placed in test 
tubes and heated to 37°C. One hundred pl of the crude acetylation mixture were 
added dropwise. during 2 min. to each of the vigorously stirred test tubes. After 
stirring for a further 15 min the reaction mixtures were analyzed by HPLC. 
Since only reaction between I’&IAc-P~IP and 2’&oxyguanosine gave a product 
which was not present in the control incubation. this reaction was scaled up by 
a factor of 5. 
The crude product from acetylation of 660 pg of N*XIH-PhIP was added, during 
10 min. to a well-stirred solution of 10 mg 2’deoxyguanosine in 10 ml 0.1 M 
BWNaOH pH 7.4 at 37°C. In the crude reaction product it was found that - 50% 
of the @-OH-PhIP had reacted with Z’deoxyguanosine. After a further 10 min 
of stining the precipitate was collected. washed with water and dried. The residue 
was taken up in 5 ml 20% DMF in chloroform and applied on a 1.6 x 9 cm column 
of silica gel equilibrated with DMF:chloroform. I:4 v/v. After washing with this 
solvent system the adduct was eluted with DMF:chloroform. 1: 1 v/v and evaporated 
to dryness. The yield of the adduct from M-OH-PW was 31%. The yield of 
adduct was calculated on the basis of experiments where [3H]-N’-OH-PhIP was 
Used. 
The synthesis was repeated several times until enough material for mass spectral 
and NMR analyses had been collected. 
Binding of N?-OAc-PhIP to DNA 
The crude product from acetylation of 500 pg of N’-OH-PhIP was added. during 
10 min, to a well-stirred 37°C solution of 4 mg calf thymus DNA in 4 ml 0.1 M 
BEWNaOH pH 7.4. After a finther 10 min of stirring, the DNA was precipitated 
by addition of 2 vol icecold ethanol, collected. dried and redissolved in 4 ml of 
water. The DNA solution was extracted twice with 4 ml of dichloromethane. 10 
remove non-covalently bound reaction products and the DNA was precipitated by 
addition of 100 pl 3 M sodium acetate and 2 vol ice-cold ethanol. 
Enqmatic hFdrol?sis of PhIP - DNA 
Calf thymus DNA that had been reacted with N?-OAc-PhIP was digested 
enzymatically and analyzed by a procedure modified after Palmgren er al. (16). 
PhIP-DNA was dissolved in a reagent glass at a concentration of 0.25 mgiml 
in 30 mM sodium acetate. 1 mM &SO, pH 5.3 and 54 U nuclease Pi and 10 U 
of alkaline phosphatase were added per ml solution. After incubation at 70°C for 
2 h, 54 U of nuclease and 10 U of alkaline phosphatase were added and incubation 
at 70°C was continued for 2 futther hours. The digest was analyzed by HPLC 
and the eluate was monitored at 260. 280. 3 16 and 360 nm Fractions (1 min) of 
the eluate from HPLC analysis of digested L3H]PhIP-DNA was collected and 
analyzed by liquid scintillation counting. The amount of PhIP bound to DNA was 
estimated to be 12 nmol/mg DNA. indicating that one out of 50 guanine residues 
had formed adducts. The yield of adducts from N’-OH-PhiP was estimated to be 
2.5%. 
Mod@uion of DNA in viva 
One adult male Wistar tat (age 8 we&s, weight 250 g), delivered from Mollegtid 
Breeding Center Ltd. Liile Skensved. Denmark. was injected i.p. with 200 mg 
PCB/kg (Aroclor 1254. dissolved in corn oil). After 5 days the rat was starved 
overnight and dosed by gavage with [‘HIPhIP (1 mgikg. 21.1 Ci/mol, dissolved 
in 70% ethanol). The animal was killed after 2 h and the liver removed. The liver 
was homogenized and the DNA was isolated by the phenol:chloroform extraction 
procedure previously described (17). The 39 mg DNA obtained was dissolved in 
15 ml of 0.1 M hydrochloric acid and hydrolyzed bl heating to l@)‘C for 1 h. 
The DNA hydrolysate was loaded onto a C , 8 SEP-PAK, which had &en wash4 
with acetonitrile and water. .4fter washing with 3 vol of water. the SEP-Pm was 
eluted with 3 ml of 10% ammonium formate pH 3.5 in acetonitrile. The eluate 
was evaporated to dryness and the residue was redissolved in 250 p1 of 80% 
acetonitrile and separated b> HPLC from which one min fractions were collected 
and analyzed by liquid scintillation counting. Synthetic S’-(2’dG-8-yI)-Ph and 
calf thymus DNA reacted with &OAc-PhIP were ltkewise hydrolyzed in 0.1 .M 
hydrochloric acid for comparison with the rat liver DNA. The hydrolvsis product 
from [3H]PhIP-DNA was purified on a SEP-PAK. Liquid scintillabon analysis 
showed that only a background level of radioactivit) was present in the water wash. 
90% of the applied radioactivie was recovered in the acetonitrile eluate. The eluate 
was anal\,zed b) HPLC and TLC (15 acctlc acid. 5$ methane! ,n ihlorof~)~nl. 
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Kinetics 
N’-acetoxy-PhIP (15 pmoles) was added to I ml of a 0.15 mM solution of 
Z’deoxyposinz in 0.1 M BWNaOH pH 7.4 held at 0°C and a control not 
containing 2’deoxyguanasine. The ractiotl mixlum were stored at 0°C and analyzed 
by HPLC every 30 min. The residual concentration of J#-acetoxy-PhIP was 
determined. 
Results 
Acetylation of N*-OH-PhIP with acetic anhydride showed two 
products when analyzed by HPLC (Figure 1). Product A seemed 
to be quite stable relative to N*-OH-PhIP, while product B was 
B 
Time(min) 
Fig. 1. Chromatogram of the etude product from acetylation of N’-OH-PhIP 
with acetic anhydride. analyzed on a Nucleosil C,,. 5 Frn 250 X 4.6 mm. 
Flow rate 0.8 mllmin. Solvents: I. 20 mM triethylamine/HCl pH 4.5 in 
water; Il. 20 mM triethylamine/HCl pH 4.5 in ethanol. Elution programming: 
isocratic 20% II by 3 min. linear gradient to 50% II by 8 min. isocratic 50% 
II by 13 min and a linear gradient to 100% II by 20 min. Peak B tentatively 
ldenntied as N’-OAc-PNP. while peak A is tentatively identified as 
N’-AC-N’-OH-PhIP. 
: 250 
(D 200 
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Fig. 2. Chromatograms. monitored at 316 and 360 mn. of the crude reaction 
mixture of aceblated I@-OH-PhIP and Z’deoxyguanosine. analyzed on a 
Nucleosil C,,. 5 pm, 25 cm x 4.6 mm. Flou rate 0.8 mlimin. Solvents: I. 
50 mM ammonium formate pH 3.5: II. acetonitrile. Elution programming: 
isocratic 20% II by 3 min. a linear gradient to 50% II by 8 min. isocratic 
50% II by 13 min and a linear gradient to 100% II by 20 min. Peak A is an 
unidentified rearrangement product of N’-OAc-PhIP. Peak B is the putative 
N’-AC-N’-OH-PNP. Peak C is N’-OH-PhIP and peak D is 2-OH-PhlP. a 
mmor impurit) in the ,Q-OH-PhIP used. N’-(2’dG-8-yl)-PhlP is the adduct 
&ruern PhIP and 2’.deoxguanosmc. 
PhIP reactions with Z’deoxyguanosine 
quite unstable and rapidly decomposed when stored at room 
temperanne at neutral pH. The stability of product B was improved 
at acidic Pi-I. Both products were purified by HPLC and analyzed 
by positive FAB mass spectrometry (spectra not shown). Both 
Peaks A md B showed a molecular ion, (M+H)‘, at m/z, 283 
and a daughter ion at 241 (loss of ketene). The mass spectra shows 
that both products are monoacetyl derivatives of N2-OH-PhIP. 
The chemical reactivities of the two compounds, relative to 
@-OH-IWP, indicate that A, which does not react with DNA or 
2’deoxymttcleosides, is N,N -acetylhydroxyamino-PhIP (N2-Ac- 
N2-OH-PI&‘) and that peak B, which does react with both DNA 
and 2’deoxyguanosine, is N2-OAc-PhIP (18). The relative yields 
:of the two products could be varied by changing the reaction con- 
ditions. Product A was exclusively observed when pyridine was 
added to the reaction mixture, while addition of acetic acid resulted 
.in formation of product B, tentatively identified as N2-OAc-PhIP, 
as the major product. 
Reaction .@$-OAc-PhIP with 2’-deoqnucleosides. Synthesis of 
#-dG-8-$1 - PhIP 
@-OAc-PhIP reacted with 2’deoxyguanosine in neutral solution. 
whereas addition of N’-OAc-PhIP to solutions of 
2’deoxyadenosine. 2’deoxycytidine, and 2’deoxythymidine only 
resulted In products which were also present in a control incubation 
not containing 2’-deoxynucleoside. Figure 2 shows a 
Z?i. 3. UV spectrum of @-(2’-dG%yl)-PhIP obtained Hith a photodiode 
artal detecaor at the e!ution conditions from the HPLC column (see Figure 
2). 
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Fi. 4. Positive ion thermospra> mass spectrum of .V’-(?‘dG-8-)I) -PhIP 
~sfrouing the molecular ion (M+H)’ at r?t/: = 490 and a duaghter ion at 
.m!: = 374. loss of deoxyibose. Solvent: 50% 0.1 M ammonium acetate pH 
4.5 in acetonitrile. tlou 1 rnlmin. source temperature 73°C. 
chromatogram of the crude product from reaction of N’-OAc- 
PhIP and 2’-deoxyguanosine. Compound B eluting at 11.5 min 
is the putative N2-AC-N2-OH-PhIP and compound D eluting at 
14 min is 2-OH-PhIP, which is a minor impurity originating from 
the synthesis of the J?-OH-PhIP. An unidentified compound 
(peak, A), with high absorption at 360 M-I, eluted at - 11 min. 
The area of this peak was much larger when 2’deoxyguanosine 
was not present in the reaction mixture, and this compound might 
be a decomposition product of p-OAc-PhIP. The adduct, which 
eluted at 12.5 min, precipitated quantitatively out of the solution 
and was further purified by silica gel chromatography, which 
removed a red colored impurity, that did not elute from the HPLC 
column. The UV spectrum of the adduct shows maxima at 364.5, 
270.5 and 238.5 nm (Figure 3). The positive ion thermospray mass 
spectrum of the purified product showed a molecular ion at 490 
(M+H)* (Figure 4), which is consistent with an adduct between 
PhIP and 2’deoxyguanosine. As shown in Figure 5, its 
[‘H]NMR spectrum in DMSO-de, revealed the presence of all 
sugar protons, the two pyridine protons (H-5 and H-7), the five 
benzene protons (H-2’- H-6’), the 2”-amino group of the base and 
of the N-Me group of PhIP. However, the characteristic C-8 pro- 
ton of guanine was not present. This observation is a strong in- 
dication that the nitrogen of the Z-amino group of PhIP was 
attached to the C-8 of 2’deoxyguanosine. That was confirmed 
through [13C]NMR spectroscopy where all 2 1 carbon atoms 
could be observed, and those with a single H bound to them were 
enhanced in the distortionless enhancement by polarization transfer 
(DEPT) experiment (see Table I). Again, the absence of a 
[“Clsignal from guanines C-9 when the DELI technique was 
employed confirms that PhIP is bound to this carbon atom. These 
results from the [‘HI- and [13C]NMR spectroscopy taken together 
with the thermospray mass spectrum corroborate that the struc- 
ture of the adduct is p-(2’dG8-yl)-PhIP. The reaction scheme 
is depicted in Figure 6. 
Table I. [ “C]NMR chemical shifts of N’-(2’-dG-8-yl)-PhIP and PhIP 
.N’-(2’-dG-S-VI, - PhIP PhIP Assienment 
153.29 
152.89 
152.74 
149 73 
148.95 
146 11 
139.48 
137.98 
129.93 
128.97* 
127.34’ 
126.79* 
125.88 
Il3.42* 
108.66 
87.37s 
82.05* 
71.32* 
62.34 
38.87 
28. I I 
157.98 
156.29 
139.29 
139.03 
127.87 
128.86 
126.56 
126.43 
126.22 
111.63 
28.40 
C-3a 
c-2 
C-6” 
C-2” 
C-4” 
C-8” 
C-5 
C-l’ 
C-7a 
C-3,.5’ 
C-4’ 
C-2’36’ 
C-6 
c-7 
C-5” 
C-4”’ 
C-1”’ 
C-3”’ 
C-5”’ 
C-2” 
N-Me 
[ “C]NMR chemical shifts of ~“-(2’-dG-8-yl)-PhIP at 20°C. referenced to 
the sobent lb (DMSO-de) 39.501. Assignments for PhIP are based on two- 
dimensional experiments and for N’-(2’-dG-8-)I) -PhIP on comparisons to 
the chemical shifts of 2’-deoxyguanosine in DMSO-d, and to those of PhIP. 
Values marked uith an asterisk are those peaks enhanced in the DEPT 
experiment. 
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Fig. 6. Reaction scheme. 
Reaction of I?-OAc-PhlP with calf thymus DNA 
iVe-OAc-PhIP reacted with calf thymus DNA giving a covalent- 
ly bound PhIP residue, which could not be removed by repeated 
precipitations, solvent extractions or dialysis against 20% ethanol 
in water. The PhIP-DNA adduct was hydrolyzed enzymatically 
with nuclease Pl and analyzed by HPLC. Figure 7 shows the 
chromatograms monitored at 260 and 360 nm of the hydrolyzed 
PhIP-DNA adduct. Peaks A-D are the four nucleosides: 
2’deoxycytidine, 2’-deoxyguanosine, 2’-deoxythymidine and 
2’deoxyadenosine respectively. Peak E coeluted with synthetic 
pi(2’dG-8-yl)-PhIP and had an identical UV spectrum. Any 
other possible adducts between PhIP and nucleosides were not 
detected to any appreciable extent, when the HPLC was monitored 
at 260 run with enhanced sensitivity. HPLC analysis of an en- 
zyme digest of [3H]PhIP-DNA followed by liquid scintillation 
counting of collected fractions showed that 50% of the applied 
radioactivity coeluted with Nz-(2’dG-8-yl)-PhIP. The remain- 
ing 50% of the applied radioactivity did not elute from the HPLC 
column. The small bump eluting at - 19.5 min may represent in- 
completely hydrolyzed DNA fragments bound to PhIP, as this 
bump was much larger and the adduct peak much smaller when 
hydrolysis was carried out at lower temperature (37°C). The high 
temperature (7O”C), which is the temperature optimum of nuclease 
Pl (19), seems to be necessary for efficient hydrolysis of this 
DNA, with a high degree of modification. HPLC analysis of a 
solution of N*-(2’dG-8-yl)-PhIP incubated at 70°C showed that 
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Fq. 5. 400 MHz ‘H-NMR spectrum of Vz(2dG-8-yl)-PhJP at 20°C. The chemical shifts are referenced to the solvent [6 (DMS0-de)2.49]: 6 = 9.9 (brs. 
6”-OH), 8.41 (d, H-5). 8.01 (d. H-7). 7.76 (d. H-2’ and H-6’). 7.49 (t, H-3’ and H-5’). 7.38 (t. HA’). 6.50 (t. H-l”‘). 6.38 (brs. 2”-NH& 4.48 
(m, H-3”‘). 3.80 (m. H4”‘). ca. 3.7 (partly hidden, H-5”‘b). 3.65 (s, N-CH,). 3.53 (dd. H-5”‘a). 3.27 (dt. H-2”‘b). 2.05 (ddd. H-2”‘a). Js,, = 2.0 Hz. 
J,,s. = 7.9 Hz, I,..,. = 7.9 Hz, J,...,2.,.n = J,...,2...b = 7.4 Hz, Jz...J,z...b = 13.7 Hz. Jz...B,j... = 2.7 Hz. J?,,.,,,,., = ca. 6 Hz. J3....1... = ca. 3 Hz, 
J4,,,5wa = JQ ,,a, 5,,,b = 5.6 Hz F& JS...a.S...b = 11.7 Hz. Inset: The aromatic region of a 400 MHz ‘H-NMR spectrum of 
sharp singlet at 6 = 7.85. i: impurity. S: sattelites (“C). 
2’deoxyguanosine showing H-8” as a 
the adduct was stable under the hydrolysis conditions. Attempts 
to hydrolyze the PhIP - DNA and liberate the adducts with DNase 
1, phosphodiesterase and alkaline phosphatase (37°C) were not 
successful. 
Modification of DNA in \i\Io 
Liver DNA from a rat dosed with [3H]PhIP was isolated and 
hydrolyzed in dilute hydrochloric acid. The hydrolysate was 
separated by HPLC and fractions were collected and analyzed by 
liquid scintillation counting. N*-(2’dG-8-yl) - PhIP and the 
PhIP - DNA adduct, made in vitro, were hydrolyzed similarly for 
comparison. The results are shown in Figure 8. Panel 1 shows 
the HPLC profile of the acid hydrolysate of the 
N*-(2’dG-8-yl)-PhIP adduct. The hydrolyzed adduct eluted at 
12 min. Panels 2 and 3 show the HPLC profde of the acid 
hydrolyzed PhIP- DNA adduct formed in vitro, monitored at 360 
and 254 nm respectively. A product eluting at the same retention 
time as in panel 1 and showing an identical UV spectrum con- 
firms the identity of the adduct formed from N*-GAc-PhIP and 
DNA to be N*-(2’-dG-&yl)-PhIP. The small peak eluting just 
before the hydrolyzed adduct peak is also present, but to a lesser 
extent in panel 1. This peak grew larger when acid hydrolysis 
was carried out for a prolonged time. This early eluting peak may 
thus represent a further degradation product of the adduct. Panel 
3 also shows that N?-(2’-dG-&yl)-PhIP is the major adduct 
formed in DNA. This is further confirmed in panel 4 showing 
PhIP reactions with 2’deoxyguanosine 
5 10 15 20 
Time (min.1 
Fig. 7. Chromatograms of the enzymatically hydrolyzed PhIP-DNA adduct 
analyzed on a Spherisorb C,,. 3 pm. 150 x 4.6 mm. Flow rate: 0.8 mUmin. 
Solvents: I. 50 mM ammonium acetate pH 4.5. II: acetonitrile. Elution 
programming: isocratic 2% II by 1 min. linear gradient to 10% II by 13 min. 
linear gradient to 40% II by 17 mm. isocratic 40% II by 20 min and a linear 
gradient to 80% II by 25 mm. Peaks A-D are Z’deoxycytidine. 
Z’deoxyguanosine. Z’deoxythymidme and Z’deoxyadenosme respecnvel) 
Peak E is A’*-(2’dG-S-yl)-PhfP. 
Fig. 8. HPLC profiles of N’-(2’dG-8-yl)lPhlP and the PhIP-DNA adduct 
subjected to acid hydrolysis. Panel 1: hydrolysate of .Y’-(2’dG-8-yl)-P~P, 
Panels 2 and 3: hydrolysate of the Or rirro formed PhLP-DNA adduct 
monitored at 360 and 25-2 nm. Peak at 4 and 6 tin in panel 3 originate 
from the calf thymus DN.4. Panel 4: hydrolysate of [‘HIPhIP-DNA formed 
in vitro. fractions were collected at I min intervals and radioactivity was 
measured b liquid scintillation counting. Panel 5: hydrolysate of liver DNA 
from a rat given [‘HIPhIP P.O. Fractions Here collected bv 1 min intervals 
and radioactivity was measured by liquid scintillation counkng. 
Fig. 9. Decay of N?-acetoxy-PhIP at 0°C versus time. +; 2’deoxyguanosine 
present in the incubation mixture, n ; Z’deoxyguanosine not present in the 
incubation mixture. 
the results from the liquid scintillation counting on fractions from 
the HPLC separation of the SEP-PAR eluate of hydrolyzed 
[ 3H]PhIP - DNA. 60% of the applied radioactivity cceluted with 
the hydrolysis product of N2-(2’dG-8-yl)-PhIP. The remaining 
40% of the radioactivity did not elute from the HPLC column. 
TLC analysis of the SEP-PAK eluate followed by liquid scintilla- 
tion counting of collected spots showed that the radioactivity that 
did not elute from the HPLC column coeluted with a product which 
was also formed when N*-acetoxy-PhIP was added to a buffer not 
containing 2’deoxyguanosine. This byproduct from the reaction 
is probably azoPhIP, formed by dimetization of two nitrenes. This 
byproduct seems to intercalate strongly into the DNA. Panel 5 
shows the results from the liquid scintillation counting on frac- 
tions from the HPLC separation of hydrolyzed liver DNA from 
a rat dosed with [3H]PhIP. The radioactivity eluting at 12 min 
indicates that PhIP, in vivo, also binds covalently to C-8 of guanine. 
Kinetics 
Results from the investigations of the reaction kinetics of 0°C 
where the reaction between N’-OAc-PhIP and 2’deoxyguanosine 
was sufficiently slow to be followed by HPLC is shown in Figure 
9. The decay of p-OAc-PhIP showed a linear relation of 
-In/C/C,) versus time, regardless of whether 2’deoxyguanosine 
was present or not. As no solvolysis product (iv*-OH-PhIP) was 
detected, this linear relation indicates that the rate was first order 
with respect to Nz-OAc-PhIP and zero order with respect to 
2’deoxyguanosine. 
Discussion 
The proximate mutagenic p-hydroxylated metabolite of the food 
mutagen PhIP (Nz-OH-PhIP) did not bind covalently to DNA or 
2’deoxyguanosine, neither at neutral pH nor at slightly acidic PH. 
Acidic pH usually increases the binding of arylhydroxylamines 
e.g. 2-hydroxyamino-3-methylimidazo[4,5-Aquinoline (M-OH- 
IQ) to DNA, since protonation of the hydroxyl group facilitates 
the formation of a reactive nitrene. The fact that acidic pH does 
not increase the degree of binding of N*-OH-PhIP to DNA, 
indicates that the heterolytic cleavage of the N -0 bond proceeds 
less readily in N2-OH-PhIP than in Nz-OH-IQ. 
Covalent binding of N-hydroxylated amines to DNA is 
generally considered to proceed via activation by cytosolic acyl- 
or sulfotransferases and the subsequent formation of reactive 
nitrenes or nitrenium ions (20). Formation of the presumed 
N-acetoxy derivatives of 2-amino-3-methylimidazo[4,5-jJquinoline 
(IQ) (2 1). 2-amino-6-methyldipyrido[ 1,2-a:3’,2’-d]imidazole 
(Glu-P-l) (22) and 3-amino-l-methyl-SWpyrido[4,3-blindole 
(Trp-P-2) (23), formed by reaction with acetic anhydride or 
ketene. have previously been shown to lead to reaction with DNA 
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and 2’-deoxyguanosine. After acetylation of N*-OH-PhIP to 
NZ-OAc-PhIP, which enhances the heterolytic cleavage of the 
N-O bond, N*-OH-PhIP reacted with both DNA and 
2’-deoxyguanosine in high yields. Isolation of N-acetoxy- 
arylamines are usually precluded by their chemical instability 
(18), but the relative stability of the N -0 bond in IV’-OAc-PhIP 
made possible its isolation and mass spectrometric characteriza- 
tion of this still rather reactive compound. 
The highest yields of adduct were obtained when N’-OAc- 
PhIP was added slowly to a 37°C solution of DNA or 
2’-deoxyguanosine. The slow addition of Nz-OAc-PhIP 
combined with its fast rate of reaction keeps the ratio between 
nucleophilic DNA or nucleoside and electrophile high, whereby 
formation of side reaction products from the putative nitrene 
intermediate is kept low. One of these side reaction products is 
probably azo-PhIP, formed by dimerization of two nitrenes, 
which is a common reaction of arylnitrenes (24). 
Analysis of the hydrolysis product of DNA, modified by 
N*-OAc-PhIP in vitro, indicated that the N*-OH-PhIP had 
mainly bound to the guanine of DNA, and since the 
nucleoside-PhIP adduct, on HPLC, coeluted with and had an 
identical UV spectrum as synthetic N*-(2’-dG-yl)-PhIP, the 
major adduct formed in vitro thus appeared to be 
N*-(2’dG-8-yl) - PhIP. 
PhIP also bound to liver DNA in vivo, upon dosing a rat with 
[3H]PhIP. Since part of the eluted radioactivity which had bound 
covalently to DNA, upon acid hydrolysis coeluted with the 
hydrolysis product of synthetic N*-(2’-dG-8-yl) -PhIP and 
PhIP-DNA made in vitro, Nz-(2’-dG-8-yl)-PhIP also 
appeared to be formed in vivo. It cannot be excluded that other 
nucleoside-PhIP adducts are formed in vivo. 
Binding of the exocyclic amino group to the C-8 position of 
guanine seems to be the most common site of reaction of activated 
heterocyclic aromatic amines with DNA. N2-OH-IQ, N*-OH- 
Glu-P-1 and Ns-OH-Trp-P-2 have formerly been shown to bind 
to DNA in a similar way, after activation with acetic anhydride 
or ketene. 
The yield of adduct from N*-OH-PhIP was 2.5% when 
N*-OAc-PhIP was reacted with DNA and 50% when N*-OAc- 
Ph.IP was reacted with 2’-deoxyguanosine. This suggests that 
intercalation of N*-OAc-PhIP into the DNA strand is not an 
important step in the binding of this N-acetoxy derivative to DNA. 
This is in contrast to findings with N’-OH-IQ and N’-OH-Glu- 
P-l, where intercalation was suggested to be of importance in 
the DNA binding of these substances (21.22). In these studies 
N*-OAc-IQ was generated in situ, by addition of acetic 
anhydride to a mixture of DNA and M-OH-IQ (21), and 
i$-GAc-Glu-P-1 was reacted with DNA at low temperature 
(22). The relatively low yield of adduct obtained when N*-OAc- 
PhIP was reacted with DNA compared to that with 2’-deoxy- 
guanosine indicates that the DNA structures reduces binding of 
Nz-OAc-PhIP to guanine, either by steric hindrance or by reduc- 
tion of the nucleophilicity of guanine, due to hydrogen bonding. 
The fast decomposition of N*-OAc-PhIP at physiological 
conditions, 37°C and pH 7.4, prevented kinetic investigations 
of the reaction between N*-OAc-PhIP and 2’-deoxyguanosine. 
Investigations of the kinetics at O”C, where the reaction between 
M-OAc-PhIP and 2’deoxyguanosine was sufficiently slow to be 
followed by HPLC, indicated that the rate was first order with 
respect to #-OAc-PhIP and zero order with respect to 
2’deoxyguanosine. This is in accordance with an SNl 
mechanism, where heterolytic fission of the N -0 bond in 
N2-OAc-PhIP leads to the formation of a reactive nitrene or 
nitrenium ion. 
From the results of this study it can be concluded that the 
proximate mutagenic N*-hydroxylated metabolite of PhIP can be 
activated by acetylation and that the resulting N*-OAc-PhIP 
reacts effectively with 2’-deoxyguanosine and DNA, resulting 
in the formation of N’-(2’-dG-8-yl) - PhIP. 
[3’P]Postlabeling analyses of DNA from various organs from 
rats dosed with PhIP, have recently been shown to result in high 
adduct levels in lung, pancreas and heart, but lower levels in 
the liver (9). The liver is usually the primary target organ for 
DNA-binding of heterocyclic amines with an exocyclic amino 
group. It can be speculated that the relatively higher stability of 
N2-OH-PhIP, as compared to N-hydroxy derivatives of other 
heterocyclic aromatic amines, may explain this different mode 
of action, as PhIP upon phase I activation to N’-OH-PhIP is 
sufficiently stable to allow its distribution throughout the whole 
organism. Adduct levels in the various organs may thus depend 
on their activity of phase II enzymes, and their DNA repair 
capacity in the various organs. 
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Microsomal metabolism of the food mutagen 
2-amino-3,4,8-trimethyl-3H-imidazo[4,5-fl-quinoxaline to mutagenic 
metabolites 
Henrik Frandsen, Preben A.Nielsen, Spiros Grivas’ and 
John C.Larsen 
h.iNte of Toxicology, National Food Agency. Morkboj Bygade 19, 
DK-2860 Ssborg, Denmark and ‘Department of Chemistty, Swedish 
University of Agricultural Sciences, PO Box 7016, UppsaIa, Sweden 
Heterocyclic aromatic amines are formed in the crust of meat 
during ordinary cooking. These aromatic amines are potent 
bacterial mutagens and also potent rodent carcinogens. 
2-Amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline 
(DiMeD&) is one of the more abundant heterocyclic aromatic 
amines, accounting for -20% of the mutagenic material 
found in cooked meat. DiMeIQx is metabolically activated, 
by hepatic microsomes from PCB treated rats, to two major 
and three minor metabolites. One major and one minor 
metabohte were identified as 2-hydroxyamino-3,4,8tri- 
methyl-3H-hnidazo[4,5-fjquinoxaline and 3,4,8-trimethyl-2- 
nitro-3H-imidazo[4,5-flquinoxaline, respectively, conflled 
by comparison of HPLC retention times, and UV and mass 
spectra of synthetic standards. Both metabolites were 
mutagenic in Salmonella typhimurium TA98 without metabolic 
activaticm. The other major metabolite was identified as 
2-amino-8-hydroxymethyl-3,4-dimethyl-3H-hnidazo[4,5-fl- 
quinoxaline by mass and NMR spectral analysis. The two 
remaining minor metabolites were identified as the Zhydroxy- 
amino- and 2-nitro- derivatives of 2-amino-8-hydroxy- 
methyl-3,4-dimethyl-3H-imidazo[4,~~quinoxaline by UV and 
mass spectral analysis. Both of these metabolites were 
mutagenic in S.typhimurium TA98 without metabolic 
activation. 
Introduction 
During frying of meat several mutagenic heteroaromatic amines 
of the aminoimidazoazaarene (AlA) type are formed in the meat 
crust. Several of these AL4 compounds have been shown to be 
carcinogenic in rats and mice when administered in the diet, 
producing tumors in a variety of organs (Wakabayashi et al., 
1992). 
A recent epidemiological investigation has indicated an 
increased risk of colorectal cancer associated with high meat 
intake and in particular with preference for browning of the meat 
surface (Gerhardsson de Verdier et al., 1991). As AL4 
compounds are present in the meat surface they may be involved 
in the etiology of human cancer. 
DiMeIQx and [2-14C]DiMeIQx were synthesized as previously described 
(Grivas. 1985). DiMeIOx was determined to have >95% purity by HPLC with 
detection at 260 nm.‘ [2-‘4C]DiMeIQx was determ&d to have >92% 
radiochemical purity by HPLC with radioactivity detection. Isccitric dehydrogenase 
(from porcine heart), nicotinamide-adeninedinucleotide-phosphate, trkodium-DL- 
isocitram and 3-(N-morpholino)propanesulfonic acid (MOPS) were obtained from 
Sigma (St Louis, MO), PCB (Aroclor 1254) was obtained from Monsanto 
(St Louis. MO). HPLC grade acetonittile was obtained from Rathbum 
(Walkerbum, UK). AII other chemicals were obtained from Merck (Darmstadt, 
FRG) and were of analytical purity, except palladium on carbon @‘d/C) and 
hydrazine hydrate which were of reagent grade. The SahnonelIa tester strain TA98 
and TA98NR were kindly provided by Professor Bruce NArnes (University of 
California. Berkeley, CA) and Professor Herbert S.Rosenktanz (University of 
Pit&burg. PA), respectively. 
Spthesis of 3,4,8-m’methyl-2-nitro-3H-imidazo[4,5-flquirwxaline 
(NOz-DiMeIQx) 
2-Amino-3,4,8-trimethyl-3H-imidazo[4,5-fquinoxaline 
(DiMeIQx) is a potent bacterial mutagen which has been identified 
in beef extracts (Takahashi et al., 1985), in smoked dried bonito 
(Kikugawa et al., 1986), in fried ground beef (Knize et al., 
1987), in fried Norwegian meat products (Becher et al., 1988), 
in fried beef (Murray et al., 1988), in fried pork (Nielsen et al., 
1988) and in cooked beef products (Turesky et al., 1988). The 
amounts of DiMeIQx found in fried meat range from 0.5 to 
1.2 pg/kg and DiMeIQx accounts for -20% of the total 
mutagenic activity found in beef fried at 300°C (Felton et al., 
DiMeIQx, 11 mg, was suspended in 1 ml of 10% tetrafhtoroboric acid, cooled 
on ice-water and 30 pl of 2 M sodium nitrite was added dropwise under stirring. 
The solution was stirred for 20 min at 0°C. The diazotization mixture was added 
dropwise to an ice-water cooled solution of 2.3 g sodium nitrite in 15 ml of water. 
The pH of the reaction miXNre was maintained at 4.5 i 0.1 by addition of lirst 
tetrafluoroboric acid and then 2 M sodium hydroxide. The NkNre was allowed 
to warm to room temperature and, after stirring for 25 tnin, the mixNre was 
neutralized with 2 M sodium hydroxide and extracted twice with 25 ml of ethyl 
acetate. The organic phase was washed with water and the water phase was 
extracted with ethyl acetate. The combined organic phase was dried with 
magnesium sulfate and evaporated to dryness. The product was purified by silica 
gel-chromatography (Kiesdlgel 60, 1.6. X 9 cm, 2.% methanol in ethyl acetate) 
and evaporated to dryness. Yield 10 mg (80%). The purity was shown to be 
>98% by HPLC (323 run). 
Synthesis of ?-h~dro~amino-3,4,8-t~meth~l-3H-imido[4,5-~quinoxnline 
(N’-OH-DiMeIQx) 
A reaction tube containing 20 mg of 10% Pd/C was evacuated for 5 mitt and 
tilled with argon. After addition of 3 ml of tetrahydrofuran (I’HP) the suspension 
was purged with argon for 2 min. The suspension was cooled on ice-water and 
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1986). In a model system DiMeIQx was also formed by heating 
creatinine, amino acids and hexoses (Grivas et al., 1985; Skog 
et al., 1992). 
Aromatic amines must undergo biotransformation to reactive 
electrophiles before they can interact with cellular rnacro- 
molecules. Studies on the metabolism of aromatic amines with 
a structure similar to DiMeIQx show that these substances are 
metabolically activated by microsomal oxidation of the exocyclic 
amino group, and that the resultant N2-hydroxy compounds are 
direct acting mutagens in the Ames Salmonella test (Yamazoe 
et al., 1983, 1988; Snyderwine et al., 1987; Holme et al., 1989; 
Turteltaub et al., 1990; Buonarati and Felton, 1990; Frandsen 
et al., 1991). 
The in vivo metabolism of DiMeIQx has previously been 
studied in conventional and germ-free rats. In this study only 
indirect mutagenic metabolites were structurally characterized 
(Knize et al., 1989). In order to further clarify the mutagenic 
activation of DiMeIQx we have studied the in vitro metabolism 
and identified five metabolites four of which were found to be 
mutagenic in the Salmonella strain TA98. 
Materials and methods 
Chemicals 
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Fig. 1. [2-‘4C]DiMeIQx and DiMeiQx were incubated for 40 minutes with hepatic microsomes from Wistar rats pretreated with PCB followed by HPLC 
analysis. PaneI 1 and 2: HPLC protiles of metabolites of [2-‘4C]DiMeIQx obtained with both an on-line radioactivity detector and a UV detector showing 
that five metabolites could be detected. Panel 3-5 Metabolites of DiMeIQx were separated on HPLC, and 0.5 min fractions were collected and tested for 
mutagenic activity in TA98 without metabolic activation (panel 3). TA98 with S9 (panel 4) and in the nitroreductase deficient strain TA98NR without 
metabolic activation (Panel 5). The experiment was conducted twice with identical results. There was a time delay of -0.5 mm to both radioactivity detector 
and fraction collector. 
10 d of hydraxine hydrate (80%) was added followed by addition of a solution Synthesis of 3,4,8-trimethyl-2-phenykuo~-3H-imiakzo[4,5-&uinaxaiine 
of 2.6 mg of NO*-DiMeIQx in 3 ml of argon purged THF. After 30 min of lphenylazoxy derivative of DiMeI@) 
&ring at 0°C the suspension was centrifuged, the supematant isolated, evaporated Nitrosobenzene, I mg, dissolved in 0.1 ml dimethylformamide @MD. was added 
to dryness under vacuum and stored at -20°C until use. to a solution of 200 pg h”-OH-DiMeIQx in 0.5 ml argon purged DMF. After 
60 
standing for 1 h at room temperature. the solution was analyzed by HPLCithermo- 
spray mass spectrometiy. 
Preparation of m ’crosomes 
Adult male Wistar rats (age 7-8 weeks. weight -200 g), delivered from 
M&l&d Breeding Center (Lille Skensved, Denmark), were used to prepare 
PCB induced hepatic microsomes. PCB (500 me/kg. dissolved in corn oil) was 
injected i.p. 5 days before sacrifice and microsomes were prepared essentially 
as described by Lake (1987). The microsomes were stored in liquid nitrogen until 
use. The protein content was determined by the method of Sedmark and Grossberg 
(1977). The concentration of P450 (Lake, 1987) was 2.3 run01 P45O/mg protein. 
The biphenyl hydroxylase activities (Yamazoe et al., 1981) were 3.0 tin-101 
2-hydroxy-biphenyl formed/(mg protein min) and 4.4 nmol4-hydroxy-biphenyl 
formed/(mg protein min). 
In vitro metabolism 
The incubation mixture consisted of: 1 mg microsomal protein/ml, 1 unit DL- 
isocitratedehydmgenaseml, 0.5 mM NADP’, 10 mM sodium-ot-&citrate and 
5 mM magnesium chloride in 50 mM MOPS, 0.15 mM KCl, pH 7.4. The mixture 
was preincubated for 2 min at 37°C before addition of 10 pg test substance 
(dissolved in 5 ~1 of DMF)/ml incubation mixture. The mixture was incubated 
at 37°C. The reaction was terminated by the addition of two volumes of ice cold 
argon purged ethanol. After centrifugation the supematant was isolated and 
analyzed by HPLC. 
An&ical 
HPLC analysis was performed on a Hewlett Packard model 1090 B liquid 
chromatograph equipped with a photo-diode array detector. Metabolites were 
separated on a Nucleosil Cs. 5 pm, 250 x 4.6 mm column obtained from HPLC 
Technology (Macclesfleld Cheshire. UK). Flow rate 0.8 mlimin. Solvents: A. 
50 mM ammonium formate, pH 3.5; B, acetoniuile. Solvent programming: 
isocratic 10% B by 1 min, a linear gradient to 25% B by 5 min, isocratic 25% 
B by 8 min, a linear gradient to 100% B by 13 min, isocratic 100% B by 15 min 
and a linear gradient to 10% B by 17 min. 
In experiments with “C-labelled substrate the effluent from the column was 
monitored by both a photo-diode array detector and an on-line radioactivity detector 
(Radiomatic, Flo-one beta, Tampa, FL) with Packhard Pica aqua scintillation 
@id (Mere&, CT). The flow rate of the scintillation liquid was four times the 
Ilowrate of me effluent. 
In experiments with unlabelled substrate the HPLC fractions were collected 
in argon ffied test tubes at 0.5 min intervals and analyzed for mutagenic activity. 
Positive ion thermospray mass spectra were obtained at a resolution of 600 
on a Profile mass spectrometer @rates. Manchester. UK). The effluent from 
the HPLC was introduced into me thermospray interphase at a flow rate of 
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0.8 mlmin. Both vaporizer and source temperature were 17O’C. The same solvent 
programming as above was used; however, in order to avoid excessive 
fragmentation the ammonium formate was substituted by 0.5% formic acid. 
NMR spectra were obtained with a Varian VXR400 spectrometer with DMSO- 
d6 as solvent. 
Mutation assay 
The Salmonella mutation assays were carried out by the standam plate incorporation 
method as described by Maron and Ames (1983). HPLC fractions were collected 
in argon tilled test tubes at 0.5 min intervals and 0.1 ml aliquots were tested 
for mutagenicity in TA98 with and without S9 mix (1 mg protein/plate) and in 
TA98NR without S9 mix. S9 mix was prepared from the liver of Aroclor 1254 
induced male Wistar rats. In assays not containing a metabolic activation system 
1 mM dithiothreitol was added in order to prevent oxidation of me test substances 
(Yamazoe et al., 1983; Frandsen er al., 1991). To 2 ml of molten top agar at 
45°C. 0.5 ml of S9 mix or 0.1 ml 20 mM dithiothreitol was added. After 2 min, 
0.1 ml of the HPLC fractions and 0.1 ml of a 7 h nutrient broth (Oxoid) culture 
of the test bacteria (l-2 x 10’ ceUs/ml) Salmonella typhimwium TA98 or 
TA98NR were added. After a gentle mixing the top agar was poured onto 20 ml 
minimal glucose plates. The number of His+ revertant colonies on each plate 
was counted after incubation for 48 h at 37°C in the dark. 2-Nitrofluorene, 
1,8dinitropyrene and 2-aminoanthracene were used as positive control mutagens 
and solvent as negative. 2-Nitrofluorene was tested without S9 mix at a 
concentration of 0.1 pglplate giving 99 * 37 revertants/plate in TA98 and 
42 * 15 revertants/plate in TA98NR. 1 ,8-Dinitropyrene was tested in TA98NR 
without S9 at a concentration of 2 *g/plate giving 3184 * 490 revertantsiplate. 
2-Aminoanthracene was tested in TA98 at a concentration of 0.1 pglplate with 
S9 mix giving 181 l 57 revertants!plate. 
Results 
Incubation of DiMeIQx with hepatic microsomes from Wistar 
rats pretreated with PCB produced five metabolites. Figure 1 
(panels 1 and 2) shows the radiochromatogram and the W  
profue, respectively, after 40 min of incubation with [2-i4C]Di- 
MeIQx. After 20 min of incubation only two major metabolites 
(A 1 and B) could be detected but longer incubation times resulted 
in increasing amounts of metabolites A2, Bl and B2. 
To assess the mutagenic activity of the metabolites, fractions 
were collected at 0.5 min intervals and tested for mutagenicity 
in Styphimutium TA98 both with and without the addition of 
8 
244 
i I 
B 
NHOH 
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Fe. 2. Reaction scheme showing the syntheses of NO,-DiMeIQx and N’-OH-DiMeIQx derivatives. Both were characterized by thermospray mass 
spectrometry showing a molecular ion (M+H)- at m/; 258 of NOz-DiMeIQx (A) and a molecular ion (M+H)- at mi; 244 with a daughter ion 228 of 
N’-OH-DiMeIQx (B). 
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metabolic activation system (S9) and in the nitroreductase 
deficient strain TA98NR without addition of S9. The mutagenic 
activity of the HPLC fractions without S9 is shown in Figure 1 
(panel 3). Fractions 21, 22, 24 -26 and 30-32 all contained 
mutagenic activity. Addition of S9 resulted in increased 
mutagenicity in fractions 2 l-23 and in a highly increased 
mutagenicity in fractions 26-27, originating from the parent 
compound. The mutagenicity in fraction 25 was still present at 
. the same level as without added activation system, whereas 
mutagenicity in fractions 30-3 1 had almost disappeared 
(Figure 1, panel 4). In the nitroreductase deficient strain TA98NR 
without S9 activation (Figure 1, panel 5) the mutagenicity of 
fractions 2 1,22 and 24 - 26 was at the same level as in TA98. 
However, the mutagenicity in fractions 30 -3 1 was reduced by 
>50% as compared with TA98. 
Fig. 3. Thermospray mass spectrum of me&Ate B showing a molecular 
ion (M+H)’ at m/z 244, indicating that B is a OH-derivative of DiMeIQx. 
7-H 
5-H 
OH 
Identi’cation of the microsomal metabolites 
2-Nitro and N2-hydroxyamino derivatives of DiMeIQx were 
synthesized by the two step procedure shown in Figure 2, and 
the compounds were characterized by UV spectroscopy and 
thermospray mass spectrometry. The positive ion thermospray 
mass spectrum of N02-DiMeIQx) showed a molecular ion 
(M+H)+ at m/z 258 (Figure 2A) and the mass spectrum of 
N*-OH-DiMeIQx showed a molecular ion (M+H)+ at m/z 244 
(Figure 2B), which confirms the structure of the two compounds. 
Further evidence that the N*-OH-DiMeIQx had been formed 
was obtained by synthesis of the phenylazoxy derivative which 
by HPLCithermospray mass spectrometric analysis showed the 
correct molecular ion (M+H)+ at m/z 333 (not shown) 
(Hashimoto ef al., 1982). The identity of metabolites Al and A2 
was determined as N*-OH-DiMeIQx and NOa-DiMeIQx, 
respectively, by comparison of retention times in HPLC, W 
spectra and mass spectra with synthetic standards. 
Metabolite B was puri!kd by preparative HPLC, and 
characterized by thermospray mass spectrometry and ‘H-NMR 
spectroscopy. The mass spectrum showed a molecular ion 
(M+H)+ at m/z 244, which the mass spectrum of N*-OH- 
DiMeIQx also did, but no daughter ion at m/z 228 (Figure 3). 
This indicates that metabolite B is hydroxylated in a different 
position of the molecule than N*-OH-DiMeIQx. As shown in 
Figure 4 the ‘H-NMR spectrum revealed the presence of all 
protons. The assignments are based on comparisons with 
literature values of the chemical shifts of DiMeIQx (Grivas, 1985) 
and on irradiation experiments. Irradiation at the 4-methyl group 
at 2.8 p.p.m. resulted in an increased signal height of the 5-H 
proton due to elimination of long range coupling between the 
4-methyl group and the 5-H proton. Similarly, irradiation at the 
CH2 group at 4.76 p.p.m. resulted in an increased signal height 
of the 7-H proton. This indicates that the 8-methyl group is 
N-Me 
4-Me 
1 3MSO 
i: impurity 
Fig. 4. The 400 MHZ ‘H-NMR spectrum of metabolite B at 20°C. The chemical shifts are referenced to the solvent [S (DMSO-d6) = 2.491; 6 = 8.78 
(s, 7-H). 8.27 (br s. 2-NH2), 7.29 (s, 5-H), 6.42 (br s, 8-OH), 4.76 (s, 8-CH,), 3.83 (s, N-Me), 2.80 (s, 4-Me). 
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oxidized to a hydroxymethyl group. The results from NMR 
experiments together with the mass spectrum corroborate that 
metabolite B is 2-amino-8-hydroxymethyl-3,4-dimethyl-3H- 
0 5 10 15 20 25 30 35 40 45 50 5.5 60 
TIME (min.) 
Fii. 5. Time course of the biotransformation of 8-OH-DiMeIQx (metabolite 
8) to metabolites Bl and B2. 
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Fig. 6. Upper panel: UV spectra obtained with a diode array detector at 
the elution conditions from the HPLC column of metabolize Bl and P-OH- 
DiMeIQx. Lower panel: UV spectra obtained with a diode array detector at 
the elution conditions from the HPLC column of metabolite B2 and 
N02-DiMeIQx. 
Micrawmal metabolism of DiMeIQx 
imidazo[4,5-flquinoxaline (8-OH-DiMeIQx). The NMR and 
mass spectroscopy data on 8-OH-DiMeIQx are in accordance 
with data published by Knize et al. (1989) on a similar compound 
isolated from urine of rats dosed with DiMeIQx. 
Incubation of purified metabolite B, 8-OH-DiMeIQx, with 
hepatic microsomes from PCB treated rats resulted in a trans- 
formation of 8-OH-DiMeIQx to metabolites Bl and B2. The time 
course of this transformation is shown in Figure 5. The initial 
disappearance of 8-OH-DiMeIQx is followed by a concomitant 
rise in the content of metabolite Bl in the incubation mixture. 
After 20 min, the levels of metabolite Bl began to plateau, 
whereas the amount of metabolite B2 increased. This time course 
indicates that 8-OH-DiMeIQx is biotransformed to metabolite Bl , 
which is further transformed to B2. 
A comparison of the W spectra of metabolites B 1 and B2 with 
the UV spectra of N*-OH-DiMeIQx and N02-DiMeIQx is 
shown in Figure 6. The spectral similarity between metabolite 
Bl and N*-OH-DiMeIQx and between metabolite B2 and 
NO*-DiMeIQx together with the time course of their formation 
indicates that metabolite Bl in the N*-OH derivative of 8-OH- 
DiMeIQx, 2-hydroxyamino-8-hydroxymethyl-3,4-dimethyl-3H- 
imidazo[4,5-flquinoxaline, and that metabolite B2 is the 2-1&o 
derivative of 8-OH-DiMeIQx, 8-hydroxymethyl-3,4-d& 
methyl-2-nitro-3S.midazo[4,5-~quinoxaline. Further evidence 
for the proposed structures of metabolites Bl and B2 was obtained 
by analyses of the metabolites by HPLC/thermospray mass 
spectrometry . 
Figure 7 (panel A) shows the mass spectrum of metabolite Bl 
having a molecular ion (M+H)+ at m/z 260. This is in 
A 
Fii. 7. HPLC thermospray mass spectza of met&o&es Bl and B2. The 
mass spectrum of Bl showed a molecular ion (M+H)’ at m/z 260 (A) and 
the mass spectrum of metabolite B2 (B) showed a molecular ion (M+H)’ 
at mi: 274. 
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Fig. 8. Reaction scheme showing the proposed microsomal metabolism of DiMeIQx. 
accordance with B 1 being 2-hydroxyamino-8-hydroxymethyl- 
3,4dimethyl-3H-imidazo[4,5-fquinoxaline. The mass spectrum 
of metabolite B2 is shown in Figure 7 (panel B). The presence 
of a small molecular ion (M+H)+ at m/z 274 is in accordance 
with B2 being 8-hydroxymethyl-3,4-dimethyl-2-nitro-3H- 
ixnidazo[4,5-fjquinoxaline. 
The proposed reaction scheme for the microsomal metabolism 
of DiMeIQx is depicted in Figure 8. Oxidation of the exocyclic 
amino group results in the formation of two direct acting 
mutagenic metabolites (N2-OH-DiMeIQx and N02-DiMeIQx). 
Hydroxylation of the methyl group in position 8 results in the 
formation of an indirect mutagenic metabolite (8-OH-DiMeIQx), 
which is further biotransformed to the two direct acting mutagenic 
metabolites N2-OH-8-OH-DiMeIQx and N02-8-OH-DiMeIQx. 
Discussion 
It is well established that heterocyclic aromatic amines of the AL4 
type are metabolically activated to proximate mutagenic 
metabolites by hydroxylation of the exocyclic amino group 
(Yarnazoe et al., 1983, 1988; Snyderwine et al., 1987; Holme 
et al., 1989; Buonarati and Felton, 1990; Turteltaub er al., 1990; 
Frandsen et al., 1991). Incubation of DiMeIQx with hepatic 
microsomes from Aroclor induced rats for 20 min resulted in 
two major metabolites, N2-OH-DiMeIQx and 8-OH-DiMeIQx, 
whereas longer incubation times resulted in three additional 
metabolites. It was thus shown that DiMeIQx was metabolized 
to a mutagenic N2-hydroxy derivative and that this metabolite 
can be further oxidized to a mutagenic nitro derivative. This 
further oxidation is an enzymatically catalyzed reaction, as 
incubation of N2-OH-DiMeIQx with microsomes resulted in the 
formation of the two nitro derivatives, whereas incubation with 
heat inactivated microsomes did not result in formation of the 
nitro derivatives (results not shown). This secondary reaction has 
not usually been observed for ALA type compounds. However, 
it has recently been reported that IQ can be biotransformed to 
a direct-acting mutagenic nitro derivative by prostaglandin-H- 
synthase (Morrison, 1993). 
Microsomal hydroxylation of DiMeIQx at the 8-methyl group 
resulted in an indirect mutagenic metabolite with a specific 
mutagenic activity comparable with the specific mutagenic activity 
of the parent compound (results not shown). This is in accordance 
with observations published by Knize et al. (1989). 2-Amino- 
3,8dimethylimidazo[4,5-Aquinoxaline (MeIQx), a compound of 
similar structure to DiMeIQx, also retains its mutagenicity after 
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8-hydroxylation (Hayatsu er al., 1987). We have also shown that 
the indirect mutagen 8-OH-DiMeIQx can be oxidized by 
microsomes to direct-acting mutagenic N2-hydroxy and nitro 
derivatives. The N2-hydroxy derivatives retained their 
mutagenic activity in the Salmonella strain TA98 with addition 
of S9 and in the TA98NR strain. However, the nitro derivatives 
almost completely lost their mutagenic activity with addition of 
S9 and lost -50% of their mutagenic activity in the nitro 
reductase deficient strain TA98NR. A reduction in the mutagenic 
activity of nitro compounds with the addition of a metabolic 
activation system is a well known phenomenon (Rosenkranz and 
Mermelstein, 1983). As can be seen from the radiochromato- 
grams in Figure 1 (panel l), the two nitro derivatives of DiMeIQx 
(A2 and B2) were produced in smaller amounts than the 
corresponding N2-hydroxy derivatives. However, the mutagenic 
activity without addition of S9 was much higher in the fractions 
containing the nitro derivatives than the fractions containing the 
N*-hydroxy derivatives. The N2-hydroxy derivatives are very 
reactive compounds, whereas the nitro-derivatives are quite 
stable. Decomposition of part of the N2-hydroxy derivative 
during fraction collection and pippeting may explain the lower 
specific mutagenic potency of the N2-hydroxy derivatives 
compared with the nitro derivatives. 
Knize et al. (1989) isolated a putative 4-OH-DiMeIQx from 
rat urine and feces as a minor metabolite compared with 8-OH- 
DiMeIQx and N2-acetyl-8-OH-DiMeIQx. In this in vitro 
experiment we did not observe any 4-OH-DiMeIQx. This may 
be due to the use of a different rat strain than Knize et al., Wistar 
versus Sprague-Dawley, or the use of different inducers, Aroclor 
versus P-naphtoflavone or none. Furthermore we have 
investigated the microsomal metabolism, therefore hepatic 
enzymes located in the cytosol, which may affect the in viva 
metabolism, were not considered. 
In conclusion DiMeIQx is metabolically transformed to several 
metabolites that still retain mutagenic activity. This seems to be 
in contrast to most other AIAs where the predominant mutagenic 
metabolite found has been the N2-hydroxy derivative of the 
parent compound. 
N2-OH-DiMeIQx is a very unstable compound and 
preliminary studies have shown that it reacts with 2’deoxy- 
guanosine to a small extent. However, acetylation of M-OH- 
DiMeIQx results in an extremely reactive product which gives 
adducts with 2’-deoxyguanosine in higher yields. Structural 
elucidation of this adduct is in progress. 
Mkrosomal metabolism of DiMeIQx 
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pormation of DNA adducts by the food mutagen 2-amino-3,4,8- 
trimethyl-3H-imidazo[4,5fquinoxaline (4&DiMeIQx) in vitro and 
in vivo. Identification of a N2-(2’-deoxyguanosin-?3-yl)-4,SDiMeIQx 
adduct 
Henrik Frandsen, Spires Grivas’, Robert J.Turesky2, 
Rotf Anderssonl, Lars O.Dragsted and John CLarsen 
Institute of Toxicology. National Food Agency. Morkhoj Bygade 19, 
DK-2860 Soborg. Denmark, ‘Depanment of Chemistry. Swedish University 
of Agricultural Sciences, S-75007 Uppsala. Sweden and ‘Nestec Ltd. 
Research Centre, CH-IO00 Lausanne 26, Switzerland 
The covalent binding of the mutagenic N2-hydroxy meta- 
bolite of the food mutagen 2-amino-3,4,8-trimethyl- 
3H-imidazo[4,5flquinoxaline (4,8-DiMelQx) to 2’-deoxy- 
nucleosides and DNA was investigated in vitro and in viva. 
N2-Hydroxy-4,8-DiMelQx reacted to a small extent spon- 
taneously with 2-deoxyguanosine. However, acetylation of 
N2-hydroxy-4,8-DiMelQx with acetic anhydride to form 
the N2-acetoxy derivative prior to reaction with 2-deoxy- 
guanosine resulted in much higher yield of adduct. N2- 
Acetoxy-4,8-DiMelQx did not form adducts with 2’-deoxy- 
adenosine, 2’-deoxycytidine or 2’-deoxythymidine. The 
adduct formed between the ,N2-OH metabolite of 4,8- 
DiMelQx and 2-deoxyguanosine was analysed by mass 
spectrometry and NMR spectroscopy and the structure of 
the adduct was shown to be N2-(2’-deoxyguanosin-8-y])- 
4,8-DiMelQx. N2-Acetoxy-4,8-DiMelQx reacted with calf 
thymus DNA and formed a covalently bound 4,8-DiMelQx 
residue, which could not be removed by repeated precipita- 
tions or solvent extractions. The 4,8-DiMelQx-DNA was 
hydrolysed enzymatically with nuclease Pi/acid phosphat- 
ase and HPLC analysis showed that 70% of the bound 
mutagen was recovered as N’-(2’-deoxyguanosin-S-yl)-4,8- 
DiMelQx. An additional minor adduct accounting for -1.5 % 
of the bound mutagen showed UV spectral characteristics 
similar to N2-(2’.deoxyguanosin-8-yl)-4,8-DiMelQx and is 
probably an undigested oligomer. 32P-Postlabelling analvsis 
of calf thymus DNA modified with 4,8-DiMelQx in V&I 
and liver DNA from rats dosed with 50 mg/kg 4,8-DiMelQx 
showed a similar adduct pattern. In both samples N’-(2’- 
deoxyguanosin-8-yl)-4,8-DiMelQx accounted for 60-70% 
of the bound mutagen. Thus, these results show that 4,8- 
DiMelQx similar to other heterocyclic amines form adducts 
with C-8 of guanine both in vitro and in viva via its N2- 
OH metabolite. 
Introduction 
Heterocyclic aromatic amines (HAAs*) formed in the meat 
crust during ordinary cooking are potent mutagens and carcino- 
gens (1). Daily exposure to these HAAs through the diet 
*Abbreviations: HAAs. heterocyclic aromatic amines; 4%DiMeIQx. 2-amino- 
3.1.8~trimethyl-3H-imidazo[45-flquinoxaline: Glu-P-l, 2.amino-6.methyl- 
pyridoj 1.2~n:3’.2’-dimidazole: Trp-P-2. i-amino-l -methyl-5H-pvrido-Il.?- 
bj-indole; IQ, 2-amino-3-methylimidazo[4.5-flquinoline; PhlP. 2-amtno- 
I-methyl-6-phenylimidazo[4.5-b]pyridine: MeIQx. 2-amino-3.&dimethyl- 
imidazo[4,5-flquinoxaline: dG. 2’-deoxyguanosine: DMF. dimethylforma- 
mide; BES, NJ-bis(?-hydroxyethyll-2-aminoethane sulfonic actd: <RAL>. 
relative adduct level. 
% Oxford Universiry Press 
may be associated with diet related cancers, e.g. colorectal 
cancer (2). 
2-Amino-3,4,8-trimethyl-3H-imidazo[4.5-~quinoxaline 
(4.8-DiMeIQx) is a potent bacterial mutagen found in a variety 
of cooked food products at levels of 0.5-1.2 l.tg/kg. In fried 
meat it accounts for -20% of the mutagenic activity (3-10). 
Covalent binding of carcinogens to nucleic acids of DNA 
is recognized as an important step in the initiation of cancer, 
and carcinogen-DNA adducts are considered to be promising 
biomarkers for DNA damage caused by chemical carcino- 
gens (11). 
HAAs must undergo bioactivation through N-oxidation of 
the exocyclic amino group to reactive N’-hydroxy derivatives. 
These derivatives can either react directly with cellular macro- 
molecules such as DNA and proteins, or prior to reaction they 
can be further activated by formation of reactive derivatives, 
such as acetate or sulfate esters (12). 
The HAAs 2-amino-6-methylpyrido[ 1,2-a:3’.2’-d]imidazole 
(Glu-P-I) (13). 3-amino-l-methyl-SH-pyrido[4,3-b]indole 
(Tip-P-3) (13) . 2-amino-3-methylimidazo[4.5-flquinoline (IQ) 
(15), 2-amino- 1 -methyl-6-phenylimidazo[4,5-b]pyridine 
(PhIP) (16-I 8) and 2-amino-3,8-dimethylimidazo[4,5-flqui- 
noxaline (MeIQx) (19) have been reported to form adducts 
with 2’-deoxyguanosine (dG). by binding of the exocyclic 
amino group of the HAA to the C-S of guanine. In addition 
to the major C-8 adducts. IQ and MeIQx have also been shown 
to form adducts with N’ of guanine to a lesser extent (20). In the 
present investigation we have examined the adduct formation of 
3%DiMeIQx. and identified N:-(2’-deoxyguanosin-8-yl)-4,8- 
DiMeIQx (dG-C8-[4,8-DiMeIQx]) as the major adduct formed 
both irz \,irro upon treament of DNA with N?-acetoxy-4.8- 
DiMeIQx and in 1,il.n after dosing rats with 4.8-DiMeIQx. 
Materials and methods 
3.8.Di\leIQz and [2- ‘?]3.8-DiMelQr uere synthesized as previously 
described (31.221. 4.8.DiMelQx was determined to ha\e >95% purity by 
HPLC wtth detection at 260 nm. The sp. act. of [2- “C)4.8-DtMeIQx was 
48.7 mCi/mmol and the radiochemical purity was determined to be >92% by 
HPLC with radioactivity detection. The [2-“C]4&DiMeIQx was diluted 
with unlabelled 4%DiMeIQx to a sp. act. of 2.4 mCi/mmol prior to use. 
N’-OH-4.8.DiMelQx and [2-“C]N’-OH-4.8-DiMeIQx were synthesized as 
previously described (23). Calf thymus DNA, 2’.deoxyadenosine, ?‘-deoxy- 
cytidine. 2’-deoxyguanosine. 2’.deoxythymidine, micrococal nuclease (N- 
3755). phosphodiesterase I (P-6877). alkaline phosphatase (P-4377) and 
nuclease PI (N-8630) from penicillium citrinum were obtained from Sigma, 
Sr Louis. MO. Acid phosphatase (from potato) and DNase I were obtained 
from Boehringer. Mannheim. Germany. [‘{-“P]ATP (7000 Ci/mmol) was 
obtained from ICN Chemicals. T-2 polynueleotide kinase were obtained from 
New England Biolabs. Soluene 350 was obtained from Packard. Meriden. CT. 
PEI-cellulose membranes were obtained from Macherey Nagel. Diiren. 
Germany. HPLC-grade acetonrtrile was obtained from Rathbum. Walkerbum. 
Scotland. All other chemicals kere obtained from Merck. Darmstadt. Germany, 
and uere of analytical purity. 
Amluicnl 
HPLC analyst\ &a< performed on a Hewlett-Packard model 1090 B liquid 
chromatograph. Ualdbronn. Germany. equipped with a photodiode array 
detector. Sucleo\tl C,. 5 urn. 250x-l mm column ua< obtained from Macherey 
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hgd The HW r& i!rl~ 0.:5 ml,‘inm. Suli?nth ‘>~L:.J: \. ‘0 ;r:.\l .i::?!:;i~f:luin 
forrnate pH 3.5; B. acetonitnie. \iith the follouing solLent programming: 
isocratic 10% B by 3 min. a linear gradient to 30% B by I5 min. a linear 
gradient to 909~ B by 22 min and a linear gradient to 109 B by 25 min. UV 
spectra were obtained with the photodiode array detector at the clution 
condftions from the HPLC column. 
Positive-ion eiectrospray ma,s spectra \\src obtalned dt a re:\olution of 600 
on a Profile mass spectrometer. Kratos. Manchester. CK. Samples \\ere 
dissolved in 0.2% formic acid In 80% acetonltrile. Rou rilte IO ylimln. 
NMR spectra were recorded on a Varian VXR--100 spectrometer \\ith 
DMSO-d6 as solvent. Scintillation counting was done on a Packard Tri-curb 
model 25OOTR liquid scintillation analyser with Hionic Flour as scintillation 
cocktail using external standardization. 
Acetylation of N’-OH-4.8.DiMelQx and rencriorl w/th 2’-tiro.r~~nr~leovlrles 
The N’-acetoxy derivative of N’-OH-4.8-DiiMeIQx was prepared immediately 
prior to reaction with 2’-deoxynucleosides. N’-OH-4.8-DiMeIQx (I mg. 
4. I pmol) was dissolved in I ml 757~ dimethylformamide (DMF) containing 
5 l,tl acetic acid and cooled to -50 “C; I2 ~1 of acetic anhydride uas added 
with stirring over IO min. Acetic acid was included in ordrr to favour O- 
acetylation and suppress formation of the N?-acetyl derivative ( 16). 
2’-Deoxynucleosides: 2’-deoxyadenosine, 2’-deoxycytidine. 2’-deoxy- 
guanosine and 2’.deoxythymidine were dissolved at a concentration of 
2 mg/ml in 0.1 M N,N-bis(2-hydroxyethyl)-2-aminoethane sulfonic acid (BES)/ 
NaOH, pH 7.4. Two millilitres of each solution and a control not containing 
2’-deoxynucleoside were placed in test tubes and cooled in ice/water. Two 
hundred millilitres of the crude acetylation mixture was added dropwise, over 
5 min. to each of the vigorously stirred test tubes. After stirring for a further 
5 min the reaction mixtures were allowed to reach room temperature and 
analysed by HPLC. 
Since only reaction between acetylated N’-OH-4.8-DiMeIQx and 2’-deoxy- 
guanosine gave a product which was not present in the control incubation. 
this reaction was scaled up by a factor of 5. The synthesis \\as repeated tv.ice. 
The product precipitated and was collected by ccntrifugation. rsdihsoi\ed 
in 25% DMF and purified by HPLC as described above. The sample was 
injected onto the HPLC column several times and fractions were collected 
and evaporated to dryness. The overall yield was 494 pg. I.0 pmul ( IZC;J. 
which was sufficient for structural characterization of the adduct. 
DNA binding of [2- “GIN?-aceto.~~--l.S-Di,CtelQ,y 
The product from acetylation of [2- “C]N-OH-4,8-DiMeIQx (200 pg. 
0.82 pmol) was added dropwise to a vigorously stirred solution of calf thymus 
DNA (1 mg/ml) in 20 ml of 0.1 M BES/NaOH, pH 7.4. at 0 “C. After 
incubation .for IO min the reaction mixture was allowed to reach room 
temperature and extracted twice with 40 ml of water-saturated butanol and 
once with 40 ml of ethyl acetate in order to remove unbound J.8-DiMeIQx. 
The DNA was precipitated by addition of I ml of 3 M sodium acetate and 
40 ml of cold ethanol. The DNA was washed with ethanol. dried and dissolved 
in 20 ml of 0.1 M BESMaOH. pH 7.1. The precipitation of the DN.A was 
repeated twice and the DNA was tinally dissolbed in water at a concentration 
of 2 mgiml and an aliquot was used for measurement of bound radioacti\It>. 
The DNA was solubilized in Soluene 350 according to the manufacturer’s 
instructions (Packard) and the bound radioactivit) \\as meahured after addition 
of IO ml of Hionic-Flour. It was estimated that 5.6% of the !V’-OH-4,8- 
DiMeIQx had bound to the DNA. corresponding to 2.3 nmol of I.%DiMeIQx/ 
mg DNA. 
Nuciease PI digestion of 4.8-DiMelQ.r-DNA 
Modified calf thymus DNA was diluted to 0.25 mg/ml with 30 mM sodium 
acetate, pH 5.3. containing I.5 mM ZnSO1, and denatured by heating on a 
boiling waterbath for 5 min followed by cooling in ice/water. The DNA was 
enzymatically hydrolysed to nucleosides by addition of 20 units of Nuclease 
Pl and I unit of acid phosphatase per ml of incubation mixture. After 
incubation at 37°C for 30 min followed by cooling in ice/water, 3 vol of cold 
ethanol was added and the precipitate was removed by centrifugation. The 
supematant, which contained >92% of the radioactivity, was evaporated to 
dryness by rotary evaporation. The residue was dissolved in a small volume 
of 10% acetonitrile in 50 mM ammonium formate, pH 3.5, and analysed by 
HPLC. The eluate was collected at I min intervals and mixed with scintillation 
cocktail for measurement of radioactivity. 
DNase/phosphodiesterase digestion of 4.SDiMelQx-DNA 
Modilied calf thymus DNA was digested to nucleosides by a procedure 
previously used for digestion of IQ-DNA and MeIQx-DNA (20). Modified 
DNA was dissolved at a concentration of 0.5 mg/ml in 5 mM Tris, IO mM 
MgCll. pH 7.5. After addition of DNase I at a concentration of 0.2 mg/ml 
the mixture was incubated for 5 h at 37’C. Phosphodiesterase I (0.03 unit/ 
ml) and alkaline phosphatase (O.-l unit/ml) were then added and incubation 
was continued at 37°C for I8 h. 
T?,? d:~::\r ‘.i JX ;;rh?r :‘urthcr proc?\,?d .I, Jc,L.j 
to .m .&itiunal Nuclsazt PI digebtion. 
~-bed ~bc\ e. or u .I\ \ub;c<rcd 
TLienty-ti\e microlitres of 2 M sodium acetate, pH 1.75. and 25 ml 80 mM 
ZnSO, \*ere Jdded per ml of Incubation mixture. After addition of 70 units 
(>t’ nuclease PI and I unit of acid phosphatase per ml of the mixture. incubation 
~L.L\ ~r~ntinusd for 1 h Jt 37-C The dlre\t ~a< further procc\ed as 
Je:\crlbrd dbo\c. 
blurs rhan 9O”r of the bound radioactivity was recu\ered m the \upernatant 
from both digestIon procedures. 
.Ilrdr/?ccition of’ Div.4 in rive 
T&o adult male Wistar rats (age 8 keeks. weight 250 g). delivered from 
>lolls$rd Breeding Center Ltd. Lille Skcnsved. Denmark. were doted by 
ga\agr \*ith 4.X-DiXleIQx (50 mgilig, dissolved in 50(7c ethanol). The animals 
\rere killed after 72 hand the liver removed. The liver uab homogenized and the 
DNA was isolated by the phenol/chloroform extraction procedure previously 
described (2-l). 
3’P-Posrlabe/ling of-I.S-DiMelQ.r-D/VA clddlucts formed in vitro and in viro 
DNA was digested to 3’-phosphodeoxynucleosides as follows: 3.75 kg of 
DNA Has digested in 50 l.tI of 20 mM sodium succinate and IO mlM CaCl?. 
pH 6.0. containing 3 units of micrococal nuclease and 0.3 units of spleen 
phosphodiesterase for 4 h at 37 “C. Samples were then lyophilized. 
3’.Phospho-dG-C8-[4,8-DiMeIQx] was used as reference substance for “P- 
po~tlabelling analysis. This compound was synthesized in the same manner 
as dG-C8-[4.8-DiMeIQx] by substitution of dG with 3’-phospho-dG. The 
product eluted earlier than dG-C8-[J.8-DiMeIQx] on HPLC, but showed an 
identical L:V spectrum. HPLC analysis following treatment of the product 
with acid phosphatase resulted in a product that co-eluted with and showed 
an UV spectrum identical with dG-C8-[4.8-DiMeIQx]. This indicates that the 
product is 3’-phospho-dG-C8-[4&DiMeIQx]. 
Samples were postlabeled under ATP limiting conditions as follows. The 
\amples uere resuspended in 20 ml of polynucleotide kinase buffer (30 mM 
Bicine. IO mM \lgCIJ. 2 mM spemudine and IO mM DTT. pH 9.6. containing 
55 pmoi of [*{-“P]ATP. follo&ed by I jtl buffer containing IO units of T4 
pol)nucleotide kinase and incubated for I h at 37°C. 
,\dducts were analysed by TLC (PEI-cellulose) developed by adapting 
previously published methods (25). Development in DI Has done overnight 
in 2.3 M NaHzPOI, pH 5.8. Development in D3 (bottom to top) was done in 
3.0 M lithium formate, 8.5 M urea. pH 3.0. D4 (rotated 90’) uas done with 
0.7 M Na?POI containing 0.5 M Tris-HCI and 8.5 M urea, pH 8.0. D5 was 
done in the same direction as D4 with I.7 M NaHzPOJ. pH 5.8. 
Kodak scientific imaging film (X-OMAT) and Du Pont Cronex intensification 
screens were used for autoradiography. DNA adducts were located on the 
plates by autoradiography by exposing the films at -80 “C for varying periods 
of time. Radioactive spots (adducts) were cut out and the radioactivity was 
quantified by Cerenkov counting. Relative adduct levels were calculated as 
described by Randerath er nl. (26). 
Results 
Reaction of ace&bed N’-OH-4,8-DiA4eIQ.r rvith I’-deoxy- 
rmcleosides 
Room temperature incubation of N?-OH-4,8-DiMeIQx with 
dG at neutral pH resulted in the formation of small amounts 
of adduct (not shown). However, acetylation of Nl-OH-4,8- 
DiMeIQx to the putative N’-acetoxy derivative prior to reaction 
with dG gave a much higher yield of adduct. Addition of N’- 
acetoxy-4,8-DiMeIQx to solutions containing 2’-deoxycytid- 
ine, 2’-deoxyadenosine or 2’-deoxythymidine only resulted in 
decomposition products which were also present in a control 
incubation not containing 2’-deoxynucleoside. Figure 1 shows 
the chromatogram of the crude product from reaction of N’- 
acetoxy-4,8-DiMeIQx with dG. The only product, not seen in 
control incubations, eluted at 21.3 min, and the UV spectrum 
recorded at the elution conditions from the column showed 
maxima at 326 and 258 nm, and a valley at 282 nm (Figure 
1, inset). The product, of which -90% precipitated from 
solution, was further purified by HPLC and characterized by 
mass spectrometry and NMR spectroscopy. The positive ion 
electrospray mass spectrum of the purified product showed a 
molecular ion [M + H]’ at 193.5 (Figure 2). which is in 
accordance with an adduct between 4.8-DiMeIQx and dG. 
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Fig. 1. Chromatogram monltorrd at 323 nm of the crude product from reaction of acet>lated .~‘-hLdroxS-1.S-D,~lelQx ulth 2’-deoxkguanosine. Inset, UV 
spectrum at the elution conditions from the column of the adduct. dG-C8-[l.8-DiEvicIQIj. eluttng to 71 .A min. 
As shown in Table I. the ‘HN,MR spectrum re\ealed the 
presence of all non-exchangeable protons: all sugar protons. 
the two aromatic protons of 4.8-DiXlelQx (H-5 and H-7) and 
the three methyl groups at N-3. C-4 and C-8 of 4.8-DiXleIQx. 
However. the characteristic signal of the C-8 proton of puanine 
at 6 7.85 p.p.m. was absent. This indicates that the exocyclic 
amino group of 4,8-DiMeIQx is attached to the C-8 of guanine. 
On the basis of the mass spectrometry and NMR analysis it 
was concluded that the structure of the adduct was ,Y’- 
(deoxyguanosin-8-yl)-4,8-DiMelQx (dG-C8-[4,8-DiMeIQx]) 
(Figure 3). 
The resonance for H-Z’cb is somewhat downfield compared 
to what is observed for 2’-deoxyguanosine. Such a downfield 
shift is considered to be due to a deshielding effect of the 
nearby guanine N-3 atom and suggests that the adduct is in a 
qn conformation (31). A similar SJW conformation of C-8 
adducts has previously been observed for other heterocyclic 
amines (20). 
The conformation of the glycosylic bond is in the alrri 
conformation in unmodified DNA. A change to s!rl conforma- 
tion in adducted DNA may ha\,e an influence on the structure 
of the DNA and on adduct persistence irk i,i\v. 
Reaction of N-‘-clceto.~-~,-4.8-DiMelQ.~- with cn(f th~ruus Delta 
[2-‘%Z]N’-acetoxy-4.8-DiMeIQx reacted with calf thymus 
DN.4. giving a covalent bound 4.8.DiXleIQx residue. Lvhich 
could not be removed by repeated solvent extractions or 
precipitations. The adduct level was 2.3 nmol/mg DNA. 
corresponding to one out of 300 guanine residues forming 
adducts. Higher adduct levels could be obtained by using a 
higher ratio of N’-acetoxy-4.8-DiMeIQx/DNA; however. this 
resulted in increasing difficulties in succesful enzymatic hydro- 
lysis of the modified DNA. HPLC analysis of heat denaturated 
[2-tqC]4,8-DiMeIQx-DNA subjected to enzymatic hydro- 
lysis with nuclease Pi/acid phosphatase shoived one major 
and a few minor peaks (Figure 4). The major peak. eiuting at 
21.3 min accounted for 707~ of the total eluted radioactivity,. 
This peak co-eluted with dG-CS-[5.8-DiXIeIQs] and had an 
identical LTV spectrum which corroborated its identity. The 
most important of the minor peaks. eluting at 20.4 min. 
accounted for 137~ of the radioactivity and this peak also had 
a UV spectrum that !vas identical to the spectrum of dG-CS- 
[J.&DiMeIQu] (Figure 5). 
HPLC analysis of [2-‘iC]1.8-Di~leIQ~-DS,~ subjected 
s 
p100- 
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e I 
c 
49q.5 
Fig. 2. Positl\e-ion electro5pra!, mass spectrum of purified dG-C8-[4,X- 
DiSlelQx] \ho\\in_r the molecular ion [Xl - H]- at III/; 493.5. 
Table I. ‘HSXIR chemical \hifts of N’-tdG-X-!I)-J.8.DiMeIQx referenced 
to the rol\ent. DLlSO-d, = 2.19 p.p.m. 
Chemical \hlft ip.p.m.~ ~lultipllclr! 
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to enzymatic hydrolysis with DNase. phosphodiesterase and 
alkaline phoqphatase. showed one major and at least four 
minor peaks (Figure 6). The major peak. \vhich accounted for 
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Fig. 4. HPLC profiles of calf thymus DNA modified with [2-“Cl4.8- 
DiMeIQx after heat denaturation and digestion with nuclease PI and acid 
phosphatase. Lower panel: UV trace monitored at 323 nm. L’pper panel: 
Fractions were collected at I min intervals and radioactivity measured by 
scintillation counting. 
Fig. 5. Comparison of the UV spectrum of dG-C8-[4,8-DiMeIQxj eluting to 
21.3 min and the UV spectrum of the minor peak eluting to 20.4 min. 
44% of the eluted radioactivity, co-eluted with and showed a 
UV spectrum identical to dG-C8-[4,8-DiMeIQx]. The four 
minor peaks, A, B, C and the peak eluting at 20.3 min also 
seen in the Nuclease PI digest, all showed UV spectra 
similar to dG-C8-[4,8-DiMeiQx]. HPLC analysis of the above 
hydrolysis product after an additional digestion with Nuclease 
Pl and acid phosphatase showed that peaks A. B and C had 
disappeared (not shown) and that the radioactivity associated 
with the dG-C8-[4,8-DiMeIQx] peak had increased to 70% 
(Figure 6). 
This indicates that the minor peaks, eluting earlier than dG- 
CS-[4,8-DiMeIQx] are incompletely digested oligomers. 
32P-Postlabelling of 4,8-DiMeIQx-DNA formed in vitro and 
in vivo 
Three adducts were detected by 3’P-postlabelling under adduct 
intensification conditions both in calf thymus DNA modified 
with #-acetoxy-4,8-DiMeIQx and in vivo. The major adduct 
co-migrated with synthetic 3’P-dG-C8-[4.8-DiMeIQx] (Figure 
7) and the two minor adducts formed in vitro also co-migrated 
with those seen in vivo, Figure 7. Thus, all adducts appear to 
be derived from the N’-hydroxy metabolite of 4,8-DiMeIQx. 
The relative adduct level (<RAL>) values under adduct 
itensification conditions from calf thymus DNA modified with 
4,8-DiMeIQx at a level of 1.0 pg/mg DNA and from rat liver 
2556 
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rh 
Fig. 6. HPLC profiles of calf thymus DNA modified with [2-“C]4.8- 
DiXTelQx after digestion with DNase. phosphodiesterase and alkaline 
phosphatase. Lower panel: UV trace monitored at 323 nm. Middle panel: 
Fractions were collected at 1 min intervals and radioactivity measured by 
scintillation counting. Upper panel: After aditional digestion with nuclease 
PI and acid phosphatase. Fractions were collected at I min intervals and 
radioactivity measured by scintillation counting. 
Table II. Relative adduct level (CRAL>) values under adduct 
intensification conditions of (I) calf thymus DNA modified with N’-acetoxy- 
4.8-DiMeIQx: (II) liver DNA from a rat dosed with 50 mg/kg of 4.8- 
DiMeIQx 
dG-C8 
Xdduct 2 
Adduct 3 
I II 
10.6~0.8X 10-J 3.54 + 2.42x 10-j 
4.1*2.5x 10-s I .43 + 0.54x 10-j 
0.8~0.4~ IO-’ 1.30 + 1.30x 10-s 
DNA adducts were measured 72 h post-exposure (average + SD, n = 3). 
DNA from an animal dosed at 50 mg/kg and analysis 72 h 
post-exposure are shown in Table II. 
Therefore, the dG-C8 adduct accounts for -70% of adducts 
in vitro and -60% of adducts in vivo under adduct intensification 
conditions. Note that adduct intensification conditions preferen- 
tially label adducts over non-modified nucleotides and provide 
an ‘overestimation’ of actual adduct levels (25). It is probable 
that these two other adducts may be incompletely digested 
oligomers, based upon the relative amount of dG-C8 in 
postlabelling versus adduct digested to the deoxynucleoside 
which was analysed by HPLC. The amount of dG-C8-[4,8- 
DiMeIQx] measured relative to other uncharacterized adducts 
or oligomers is comparable to what has been reported for other 
heterocyclic amines assayed by 32P-postlabelling ( 18,27,28). 
Discussion 
4.8-DiMeIQx is, like other HAAs, biotransformed to a muta- 
genic metabolite by oxidation of the exocyclic amino group 
Fig. 7. “P-Postlabelling of calf thymus DNA modified with N-acetouy-4.X- 
DiMeIQx (upper). rat liver DNA 72 h following exposure to 4.8.DiMelQx 
(50 mpkg) (middle) and 3’.phospho-dG-C8-[4.&DiMelQx] (lower). 0 = 
origin: adduct I = dG-C8-[4%DiMelQx]. 
to the N’-hydroxy derivative (22). Although N-OH-4.8- 
DiMeIQx at room temperature spontaneously reacts to a small 
extent with dG to form an adduct. acetylation of the N-OH- 
4,8-DiMelQx to the putative N’-acetoxy derivative prior to 
reaction with dG resulted in a much more reacti\,e species. 
giving much higher yields of adducts. Formation of the 
presumed N’-acetoxy derivative of Glu-P-l. Trp-P-2. MeIQx 
and PhIP by reaction with either acetic anhydride or ketene 
prior to reaction with dG have previously been shown to result 
in efficient adduct formation (13.14.16.18.29). 
The synthesis of the N’-acetoxy-4,8-DiMeIQx was per- 
formed at -50°C. because of the rapid decomposition of 
N’-acetoxy-4.8-DiMeIQx at temperatures above -30°C. The 
reaction with deoxynucleosides and DNA was performed at 
0°C. At this temperature the highest yield of adduct \vas 
obtained: at higher temperatures the N’-acetoxy-4.8-DiMeIQx 
probably decomposed before it could efficiently react with the 
dG or DNA. 
N’-Acetoxy-4%DiMeIQx reacted with dG. but not with 
other deoxynucleosides, giving dG-C8-[4.8-DiMeIQx] in high 
yield. Similarly. other heterocyclic aromatic aminea. IQ (15). 
Glu-P-l (13). TrpP-2 (14). PhIP (16-18) and MeIQx (19) 
have been reported to form adducts with dG. by binding of 
the exocyclic amino group of the aromatic amine to the C-8 
of puanine. Ho\vever. Tureskl et rrl. (20) have recently reported 
that IQ and %lelQx. in additjon to the major C-S adduct. ;II\o 
form minor adducts where the C-5 of the aromatic amine is 
attached to the N’ of guanine. These minor adducts sho\l,ed 
UV spectra dissimilar to the UV spectra of the major C-8 
Formation of 4,8-DiMeIQx-DNA adducts 
adducts. Although 4.8-DiMeIQx. MeIQx and IQ are com- 
pounds of similar structure. we did not observe indications of 
a minor adduct in addition to the dG-C8-[4,8-DiMeIQx] adduct. 
4.8-DiMeIQx. in contrast to IQ and MeIQx. has a methyl 
group in position 4 of the aromatic ring system. Steric hindrance 
by this methyl group probably prevents nucleophilic attack by 
the ‘-amino group of guanine on the C-5 of 4,8-DiMeIQx. 
N’-Acetoxy-4.8-DiMeIQx also readily reacted with calf 
thymus DNA. HPLC analysis of the modified DNA after heat 
denaturation and enzymatic hydrolysis showed that 70% of 
the bound radioacti\:ity co-eluted with dG-C8-[4,%DiMeIQx]. 
However. one minor peak elutinp earlier and accounting for 
14% of the bound radioactivity was also present. This earlier 
eluting compound had a UV spectrum which was identical to 
the UV spectrum of dG-C8-[4.8-DiMeIQx]. Some additional 
minor peaks were too small for UV spectral analysis. However. 
digestion of the modified DNA with DNase. phosphodiesterase 
and alkaline phosphatase resulted in a hydrolgsate where dG- 
CS-[4.8-DiMeIQx] only accounted for 449 of the radioactivity. 
In addition. four earlier eluting peaks with UV spectra similar 
to dG-C8-[1.8-DiMeIQx] could be identified. The radioactivit> 
associated with three of these peaks was added to the dG-CS- 
[4.8-DiMeIQxJ peak after further hydrolysis with nuclease Pl 
and acid phosphatase (Figure 6). This indicates that enzymatic 
hydrolgsi% is incomplete and results in the presence of oligo- 
mers. Furthermore. increasing the degree of modification of 
the DNA with this bulk) adduct resulted in less efficient 
enzymatic hydrolysis. 
“‘P-Postlabelling analysis of modified calf thymus DNA and 
liver DNA from rats dosed with 4.8-DiMeIQx showed a similar 
adduct pattern. dG-C8-[4.8-DiMeIQx] accounted for 60-709 
of the measured radioactivity, and two minor adducts. probably 
undigested olipomers. accounted for 15-30% and 5-209 of 
the radioacti\,ity respecti\,elj,. These results are comparable 
with the results from HPLC analysis of DSA modified in \Gtm. 
4.8-DiMeIQx DNA adduct formation ill IY’~E analysed by the 
.“P-postlabellinp technique ha\-e pre\ iously been described. 
resulting in three major and tv,o minor adducts in liver DNA 
of rats feed 4.8-DiMeIQx (30). It has. however. recently 
been shonn that the number of adduct spots found in the 
postlabelling assay of DNA adducted with HAAs are reduced 
when an additional nuclease PI digestion is included in the 
assa! (32). It is suggested that man! of the additional adduct 
spots obser\.ed are oligomers. This IS in accordance with OUI 
obser\,ation that additional nuclease digestion or nuclease 
digestion of heat-denatured DNA results in a reduced number 
of adduct peaks. 
We have recently reported that 4.8-DiMeIQx is metabolized 
irr ~Yrl-o to the direct-acting mutagenic N’-hydroxy-4.8- 
Di34eIQx and an indirect-acting mutagenic 8-hydroxymethyl 
deri\,atiI;e t8-CH?OH-3.8-DiMeIQx). Moreo\,er. prolonged 
incubation times also resulted in formation of a direct-acting 
mutagenic N-hydrox! derivative of the 8-CH,OH-4,8- 
DiMeIQx (22). The adduct patterns. as measured by j2P- 
postlabelling analvsih. ber\\een DKA modified VI ith &“-ace- , 
toxy-4.8-DiMeiQx and DXA modified in l.i\w were similar. 
This indicates that activation of 8-CH?OH-4.8-DiMeIQx to a 
DNA-reacti1.e species does not take place irl IY\Y~ to an!’ 
appreciable extent. because additional adduct spots. originating 
f‘rom S-CH~OH--?.X-Di~lelQ\. ~4 oulti ha\ e been e\pcctcd to 
be present in “P-postlabelling analysis of DNA modified 
i/l \Y\Y~ as compared to DSA moditied with Ai’-acetoxy-4,8- 
DihleIQ\. 
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In conclusion, metabolic activation of 4&DiMeIQx to the 
N2-hydroxy derivative results in formation of DNA adducts 
in vivo as well as in in vitro. The N’-hydroxy derivative either 
directly reacts with dG of DNA or reacts after esterification 
to a more reactive species, resulting in formation of dG-CS- 
[4,8-DiMeIQx] as the major adduct. 
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